421 results on '"D. Driscoll"'
Search Results
2. High-resolution microbiome analysis reveals exclusionary Klebsiella species competition in preterm infants at risk for necrotizing enterocolitis
- Author
-
Spencer Coleman, Katrin Unterhauser, Karim Rezaul, Nagender Ledala, Stephanie Lesmes, Melissa J. Caimano, Yanjiao Zhou, Eric Jackson, Dawn Gratalo, Mark D. Driscoll, and Adam P. Matson
- Subjects
Medicine ,Science - Abstract
Abstract Intestinal colonization with Klebsiella has been linked to necrotizing enterocolitis (NEC), but methods of analysis usually failed to discriminate Klebsiella species or strains. A novel ~ 2500-base amplicon (StrainID) that spans the 16S and 23S rRNA genes was used to generate amplicon sequence variant (ASV) fingerprints for Klebsiella oxytoca and Klebsiella pneumoniae species complexes (KoSC and KpSC, respectively) and co-occurring fecal bacterial strains from 10 preterm infants with NEC and 20 matched controls. Complementary approaches were used to identify cytotoxin-producing isolates of KoSC. Klebsiella species colonized most preterm infants, were more prevalent in NEC subjects versus controls, and replaced Escherichia in NEC subjects. Single KoSC or KpSC ASV fingerprinted strains dominated the gut microbiota, suggesting exclusionary Klebsiella competition for luminal resources. Enterococcus faecalis was co-dominant with KoSC but present infrequently with KpSC. Cytotoxin-producing KoSC members were identified in most NEC subjects and were less frequent in controls. Few Klebsiella strains were shared between subjects. We conclude that inter-species Klebsiella competition, within an environment of KoSC and E. faecalis cooperation, appears to be an important factor for the development of NEC. Preterm infants seem to acquire Klebsiella primarily through routes other than patient-to-patient transmission.
- Published
- 2023
- Full Text
- View/download PDF
3. GATA1 deletion in human pluripotent stem cells increases differentiation yield and maturity of neutrophils
- Author
-
Thomas C. Harper, Elaine M. Oberlick, Tomas J. Smith, Duncan E. Nunes, Mark-Anthony Bray, Seonmi Park, Corey D. Driscoll, Sarah F. Mowbray, and Christophe Antczak
- Subjects
Immunology ,Stem cells research ,Methodology in biological sciences ,Science - Abstract
Summary: Human pluripotent stem cell (hPSC)-derived tissues can be used to model diseases in cell types that are challenging to harvest and study at-scale, such as neutrophils. Neutrophil dysregulation, specifically neutrophil extracellular trap (NET) formation, plays a critical role in the prognosis and progression of multiple diseases, including COVID-19. While hPSCs can generate limitless neutrophils (iNeutrophils) to study these processes, current differentiation protocols generate heterogeneous cultures of granulocytes and precursors. Here, we describe a method to improve iNeutrophil differentiations through the deletion of GATA1. GATA1 knockout (KO) iNeutrophils are nearly identical to primary neutrophils in form and function. Unlike wild-type iNeutrophils, GATA1 KO iNeutrophils generate NETs in response to the physiologic stimulant lipopolysaccharide, suggesting they are a more accurate model when performing NET inhibitor screens. Furthermore, through deletion of CYBB, we demonstrate that GATA1 KO iNeutrophils are a powerful tool in determining involvement of a given protein in NET formation.
- Published
- 2023
- Full Text
- View/download PDF
4. Treatment of Hodgkin Lymphoma With ABVD Chemotherapy in Rural Rwanda: A Model for Cancer Care Delivery Implementation
- Author
-
Rebecca J. DeBoer, Cyprien Shyirambere, Caitlin D. Driscoll, Yvan Butera, Alan Paciorek, Deogratias Ruhangaza, Temidayo A. Fadelu, Aline Umwizerwa, Jean Bosco Bigirimana, Clemence Muhayimana, Cam Nguyen, Paul H. Park, Tharcisse Mpunga, Leslie Lehmann, and Lawrence N. Shulman
- Subjects
Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
PURPOSE Hodgkin lymphoma (HL) is highly curable in high-income countries (HICs), yet many patients around the world do not have access to therapy. In 2012, cancer care was established at a rural district hospital in Rwanda through international collaboration, and a treatment protocol using doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) without radiotherapy was implemented. METHODS We conducted a retrospective cohort study of all patients with confirmed HL seen at Butaro Hospital from 2012 to 2018 to evaluate quality indicators and clinical outcomes. RESULTS Eighty-five patients were included (median age, 16.8 years; interquartile range, 11.0-30.5 years). Ten (12%) were HIV positive. Most had B symptoms (70%) and advanced stage (56%) on examination and limited imaging. Of 21 specimens evaluated for Epstein-Barr virus, 14 (67%) were positive. Median time from biopsy to treatment was 6.0 weeks. Of 73 patients who started ABVD, 54 (74%) completed 6 cycles; the leading reasons for discontinuation were treatment abandonment and death. Median dose intensity of ABVD was 92%. Of 77 evaluable patients, 33 (43%) are in clinical remission, 27 (36%) are deceased, and 17 (22%) were lost to follow-up; 3-year survival estimate is 63% (95% CI, 50% to 74%). Poorer performance status, advanced stage, B symptoms, anemia, dose intensity < 85%, and treatment discontinuation were associated with worse survival. CONCLUSION Treating HL with standard chemotherapy in a low-resource setting is feasible. Most patients who completed treatment experienced a clinically significant remission with this approach. Late presentation, treatment abandonment, and loss to follow-up contribute to the discrepancy in survival compared with HICs. A strikingly younger age distribution in our cohort compared with HICs suggests biologic differences and warrants further investigation.
- Published
- 2020
- Full Text
- View/download PDF
5. GATA1knockout in human pluripotent stem cells generates enhanced neutrophils to investigate extracellular trap formation
- Author
-
Thomas C. Harper, Elaine M. Oberlick, Tomas J. Smith, Duncan E. Nunes, Mark A. Bray, Seonmi Park, Corey D. Driscoll, Sarah F. Mowbray, and Christophe Antczak
- Abstract
Human pluripotent stem cell (hPSC)-derived tissues can be used to model diseases and validate targets in cell types that are challenging to harvest and study at-scale, such as neutrophils. Neutrophil dysregulation, specifically unbalanced neutrophil extracellular trap (NET) formation, plays a critical role in the prognosis and progression of multiple diseases, including COVID-19. hPSCs can provide a limitless supply of neutrophils (iNeutrophils) to study these processes and discover and validate targetsin vitro. However, current iNeutrophil differentiation protocols are inefficient and generate heterogeneous cultures consisting of different granulocytes and precursors, which can confound the study of neutrophil biology. Here, we describe a method to dramatically improve iNeutrophils’ yield, purity, functionality, and maturity through the deletion of the transcription factorGATA1. GATA1knockout (KO) iNeutrophils are nearly identical to primary neutrophils in cell surface marker expression, morphology, and host defense functions. Unlike wild type (WT) iNeutrophils,GATA1KO iNeutrophils generate NETs in response to the physiologic stimulant lipopolysaccharide (LPS), suggesting they could be used as a more accurate model when performing small-molecule screens to find NET inhibitors. Furthermore, through CRSPR/Cas9 deletion ofCYBBwe demonstrate thatGATA1KO iNeutrophils are a powerful tool in quickly and definitively determining involvement of a given protein in NET formation.
- Published
- 2023
6. GATA1 Knockout in Human Pluripotent Stem Cells Generates Enhanced Neutrophils to Investigate Extracellular Trap Formation
- Author
-
Thomas C. Harper, Elaine M. Oberlick, Tomas J. Smith, Duncan E. Nunes, Mark A. Bray, Seonmi Park, Corey D. Driscoll, Sarah F. Mowbray, and Christophe Antczak
- Published
- 2023
7. A Remote Surveillance Platform to Monitor General Care Ward Surgical Patients for Acute Physiologic Deterioration
- Author
-
Jeanine P. Wiener-Kronish, Kalpan Tolia, Milcho Nikolov, Kyan C. Safavi, William D. Driscoll, and Hao Deng
- Subjects
medicine.medical_specialty ,Quality management ,Clinical Sciences ,Vital signs ,MEDLINE ,Ophthalmologic Surgical Procedures ,law.invention ,Anesthesiology ,law ,Predictive Value of Tests ,Original Research Articles ,medicine ,Electronic Health Records ,Humans ,Original Clinical Research Report ,Monitoring, Physiologic ,Quality Indicators, Health Care ,Inpatients ,business.industry ,Clinical Laboratory Techniques ,Vital Signs ,Neurosciences ,medicine.disease ,Intensive care unit ,Quality Improvement ,Telemedicine ,Otorhinolaryngologic Surgical Procedures ,Anesthesiology and Pain Medicine ,Treatment Outcome ,Otorhinolaryngology ,Clinical Alarms ,General Surgery ,Feasibility Studies ,Observational study ,Electronic data ,Medical emergency ,business ,Hospital Units ,Software - Abstract
Author(s): Safavi, Kyan C; Deng, Hao; Driscoll, William; Nikolov, Milcho; Tolia, Kalpan; Wiener-Kronish, Jeanine P | Abstract: BackgroundThe traditional paradigm of hospital surgical ward care consists of episodic bedside visits by providers with periodic perusals of the patient's electronic health record (EHR). Vital signs and laboratory results are directly pushed to the EHR but not to providers themselves. Results that require intervention may not be recognized for hours. Remote surveillance programs continuously monitor electronic data and provide automatic alerts that can be routed to multidisciplinary providers. Such programs have not been explored in surgical general care wards.MethodsWe performed a quality improvement observational study of otolaryngology and ophthalmology patients on a general care ward from October 2017 to March 2019 during nighttime hours (17:00-07:00). The study was initiated due to the loss of on-site anesthesiology resources that historically helped respond to acute physiologic deterioration events. We implemented a remote surveillance software program to continuously monitor patients for severe vital signs and laboratory abnormalities and automatically alert the ward team and a remote critical care anesthesiology team. The primary end point was the true positive rate, defined as the proportion of alerts that were associated with a downstream action that changed the care of the patient. This was determined using systematic chart review. The secondary end point, as a measure of alarm fatigue, was the average number of alerts per clinician shift.ResultsThe software monitored 3926 hospital visits and analyzed 1,560,999 vitals signs and 16,635 laboratories. It generated 151 alerts, averaging 2.6 alerts per week. Of these, 143 (94.7%) were numerically accurate and 8 (5.3%) were inaccurate. Hypoxemia with oxygen saturation l88% was the most common etiology (92, 63%) followed by tachycardia g130 beats per minute (19, 13.3%). Among the accurate alerts, 133 (88.1%) were true positives with an associated clinical action. Actions included a change in management 113 (67.7%), new diagnostic test 26 (15.6%), change in discharge planning 20 (12.0%), and change in level of care to the intensive care unit (ICU) 8 (4.8%). As a measure of alarm fatigue, there were 0.4 alerts per clinician shift.ConclusionsIn a surgical general care ward, a remote surveillance software program that continually and automatically monitors physiologic data streams from the EHR and alerts multidisciplinary providers for severe derangements provided highly actionable alarms at a rate that is unlikely to cause alarm fatigue. Such programs are feasible and could be used to change the paradigm of monitoring.
- Published
- 2021
8. Speech perception in children with speech sound disorder.
- Author
-
H. Timothy Bunnell, N. Carolyn Schanen, Linda D. Vallino, Thierry G. Morlet, James B. Polikoff, Jennette D. Driscoll, and James T. Mantell
- Published
- 2007
- Full Text
- View/download PDF
9. Catastrophic Thinking and Pain Alleviation After Lower Extremity Surgery
- Author
-
David Ring, David C. Laverty, Matthew D. Driscoll, Carl A Nunziato, Karl M. Koenig, and Amirreza Fatehi
- Subjects
medicine.medical_specialty ,Cross-sectional study ,MEDLINE ,Logistic regression ,03 medical and health sciences ,0302 clinical medicine ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Depression (differential diagnoses) ,Pain Measurement ,Pain, Postoperative ,030222 orthopedics ,business.industry ,Catastrophization ,030208 emergency & critical care medicine ,General Medicine ,Evidence-based medicine ,Cognitive bias ,Analgesics, Opioid ,Cross-Sectional Studies ,Lower Extremity ,Opioid ,Pill ,Physical therapy ,Surgery ,business ,medicine.drug - Abstract
Objectives Requests for opioid pain medication more than a few weeks after surgery are associated with greater symptoms of depression and cognitive biases regarding pain such as worst-case thinking and fear of painful movement. We sought factors associated with patient desire for more opioid medication and satisfaction with pain alleviation at suture removal after lower extremity surgery. Design Cross sectional study. Setting Enrollment occurred at 1 of 4 orthopaedic offices in an urban setting. Patients/participants At suture removal after lower extremity surgery, 134 patients completed questionnaires measuring catastrophic thinking, ability to reach goals and continue normal activities in spite of pain, symptoms of depression, and magnitude of physical limitations. Main outcome measurements Psychological factors associated with questionnaire-reported patient desire for another opioid prescription, satisfaction with postoperative pain alleviation, and the self-reported number of pills remaining from original opioid prescription. Results In logistic regression, smoking and greater catastrophic thinking were independently associated with desire for opioid refill (R2 = 0.20). Lower satisfaction with pain alleviation was associated with greater catastrophic thinking (R2 = 0.19). The size of surgery (large vs. medium/small procedure) was not associated with pain alleviation or satisfaction with pain alleviation. Conclusions The association between unhelpful cognitive bias regarding pain and request for more opioids reinforces the importance of diagnosing and addressing common misconceptions regarding pain in efforts to help people get comfortable. Level of evidence Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.
- Published
- 2021
10. Finding the right fit: evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data
- Author
-
Jeanette L. Gehrig, Daniel M. Portik, Mark D. Driscoll, Eric Jackson, Shreyasee Chakraborty, Dawn Gratalo, Meredith Ashby, and Ricardo Valladares
- Subjects
Microbiota ,RNA, Ribosomal, 16S ,Humans ,Metagenome ,General Medicine ,Metagenomics ,Sequence Analysis, DNA - Abstract
A long-standing challenge in human microbiome research is achieving the taxonomic and functional resolution needed to generate testable hypotheses about the gut microbiota’s impact on health and disease. With a growing number of live microbial interventions in clinical development, this challenge is renewed by a need to understand the pharmacokinetics and pharmacodynamics of therapeutic candidates. While short-read sequencing of the bacterial 16S rRNA gene has been the standard for microbiota profiling, recent improvements in the fidelity of long-read sequencing underscores the need for a re-evaluation of the value of distinct microbiome-sequencing approaches. We leveraged samples from participants enrolled in a phase 1b clinical trial of a novel live biotherapeutic product to perform a comparative analysis of short-read and long-read amplicon and metagenomic sequencing approaches to assess their utility for generating clinical microbiome data. Across all methods, overall community taxonomic profiles were comparable and relationships between samples were conserved. Comparison of ubiquitous short-read 16S rRNA amplicon profiling to long-read profiling of the 16S-ITS-23S rRNA amplicon showed that only the latter provided strain-level community resolution and insight into novel taxa. All methods identified an active ingredient strain in treated study participants, though detection confidence was higher for long-read methods. Read coverage from both metagenomic methods provided evidence of active-ingredient strain replication in some treated participants. Compared to short-read metagenomics, approximately twice the proportion of long reads were assigned functional annotations. Finally, compositionally similar bacterial metagenome-assembled genomes (MAGs) were recovered from short-read and long-read metagenomic methods, although a greater number and more complete MAGs were recovered from long reads. Despite higher costs, both amplicon and metagenomic long-read approaches yielded added microbiome data value in the form of higher confidence taxonomic and functional resolution and improved recovery of microbial genomes compared to traditional short-read methodologies.
- Published
- 2022
11. Finding the right fit: A comprehensive evaluation of short-read and long-read sequencing approaches to maximize the utility of clinical microbiome data
- Author
-
Mark D. Driscoll, Jeanette L. Gehrig, Eric Jackson, Ricardo Valladares, Meredith Ashby, Dawn Gratalo, Shreyasee Chakraborty, and Daniel M. Portik
- Subjects
Metagenomics ,Strain (biology) ,Human microbiome ,Computational biology ,Microbiome ,Accession number (bioinformatics) ,Amplicon ,Biology ,Genome ,Deep sequencing - Abstract
A longstanding challenge in human microbiome research is achieving the taxonomic and functional resolution needed to generate testable hypotheses about the gut microbiome’s impact on health and disease. More recently, this challenge has extended to a need for in-depth understanding of the pharmacokinetics and pharmacodynamics of clinical microbiome-based interventions. Whole genome metagenomic sequencing provides high taxonomic resolution and information on metagenome functional capacity, but the required deep sequencing is costly. For this reason, short-read sequencing of the bacterial 16S ribosomal RNA (rRNA) gene is the standard for microbiota profiling, despite its poor taxonomic resolution. The recent falling costs and improved fidelity of long-read sequencing warrant an evaluation of this approach for clinical microbiome analysis. We used samples from participants enrolled in a Phase 1b clinical trial of a novel live biotherapeutic product to perform a comparative analysis of short-read and long-read amplicon and metagenomic sequencing approaches to assess their value for generating informative and actionable clinical microbiome data. Comparison of ubiquitous short-read 16S rRNA amplicon profiling to long-read profiling of the 16S-ITS-23S rRNA amplicon showed that only the latter provided strain-level community resolution and insight into novel taxa. Across all methods, overall community taxonomic profiles were comparable and relationships between samples were conserved, highlighting the accuracy of modern microbiome analysis pipelines. All methods identified an active ingredient strain in treated study participants, though detection confidence was higher for long-read methods. Read coverage from both metagenomic methods provided evidence of active ingredient strain replication in some treated participants. Compared to short-read metagenomics, approximately twice the proportion of long reads were assigned functional annotations (63% vs. 34%). Finally, similar bacterial metagenome-assembled genomes (MAGs) were recovered across short-read and long-read metagenomic methods, although MAGs recovered from long reads were more complete. Overall, despite higher costs, long-read microbiome characterization provides added scientific value for clinical microbiome research in the form of higher taxonomic and functional resolution and improved recovery of microbial genomes compared to traditional short-read methodologies.Data SummaryAll supporting data, code and protocols have been provided within the article or as supplementary data files. Two supplementary figures and four supplementary tables are available with the online version of this article. Sequencing data are accessible in the National Center for Biotechnology Information (NCBI) database under BioProject accession number PRJNA754443. The R code and additional data files used for analysis and figure generation are accessible in a GitHub repository (https://github.com/jeanette-gehrig/Gehrig_et_al_sequencing_comparison).Impact StatementAccurate sequencing and analysis are essential for informative microbiome profiling, which is critical for the development of novel microbiome-targeted therapeutics. Recent improvements in long-read sequencing technology provide a promising, but more costly, alternative to ubiquitous short-read sequencing. To our knowledge, a direct comparison of the informational value of short-read and HiFi long-read sequencing approaches has not been reported for clinical microbiome samples. Using samples from participants in a Phase 1b trial of a live biotherapeutic product, we compare microbiome profiles generated from short-read and long-read sequencing for both amplicon-based 16S ribosomal RNA profiling and metagenomic sequencing. Though overall taxonomic profiles were similar across methods, only long-read amplicon sequencing provided strain-level resolution, and long-read metagenomic sequencing resulted in a significantly greater proportion of functionally annotated genes. Detection of a live biotherapeutic active ingredient strain in treated participants was achieved with all methods, and both metagenomic methods provided evidence of active replication of this strain in some participants. Similar taxonomies were recovered through metagenomic assemblies of short and long reads, although assemblies were more complete with long reads. Overall, we show the utility of long-read microbiome sequencing in direct comparison to commonly used short-read methods for clinically relevant microbiome profiling.
- Published
- 2021
12. Emancipatory Praxis for Cervical Cancer Health Equity in Guatemala
- Author
-
Rhonda Goodman and Susan D. Driscoll
- Subjects
Community and Home Care ,Cervical cancer ,Nursing (miscellaneous) ,Praxis ,media_common.quotation_subject ,medicine.disease ,Health equity ,03 medical and health sciences ,0302 clinical medicine ,Nursing ,030220 oncology & carcinogenesis ,Political science ,medicine ,030212 general & internal medicine ,Care Planning ,media_common - Abstract
This study explores barriers and facilitators to cervical cancer screening among indigenous Maya women in Guatemala. Eight weeks of observation, active participation, informal interviews, and semistructured interviews with community organizers were analyzed using Leininger's 4-phase process to elucidate five themes: fear/shame, “machismo,” education/experience, cost, and self-love. Results suggest sustainable cervical cancer screening may be possible through cultural humility, collaboration, balance of power, and emancipatory praxis. Practicing these concepts may help to build knowledge and trust between providers and community, thereby lessening oppression, empowering women, and reducing cervical cancer health disparities and disease burden among Guatemalan Maya women.
- Published
- 2019
13. Does resiliency mediate the association of psychological adaptability with disability and pain in patients with an upper extremity injury or illness?
- Author
-
David Ring, Mark H.F. Keulen, Lee M. Reichel, Gregg A. Vagner, Joost T.P. Kortlever, Matthew D. Driscoll, and Teun Teunis
- Subjects
Adult ,Male ,Coping (psychology) ,medicine.medical_specialty ,Mediation (statistics) ,Adolescent ,media_common.quotation_subject ,Protective factor ,Structural equation modeling ,Upper Extremity ,Disability Evaluation ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Surveys and Questionnaires ,Psychological adaptation ,Adaptation, Psychological ,medicine ,Humans ,Longitudinal Studies ,Prospective Studies ,030212 general & internal medicine ,Aged ,Pain Measurement ,media_common ,Aged, 80 and over ,business.industry ,Confounding ,Middle Aged ,Psychiatry and Mental health ,Clinical Psychology ,Mood ,Physical therapy ,Female ,Psychological resilience ,business ,030217 neurology & neurosurgery - Abstract
Objective Symptom intensity and magnitude of limitations are highly variable for a given nociception and pathophysiology. As psychological determinants are of great influence to physical wellbeing, we assessed the influence of the protective factor measured and labelled as resilience in upper extremity illness. Methods One hundred and six patients completed a survey of demographics, the Brief Resilience Scale (BRS), the Psychological Adaptation Scale (PAS), an 11-point ordinal measure of pain intensity, and the PROMIS Physical Function (PROMIS PF) Computer Adaptive Test (CAT). Measures of pain intensity and PROMIS PF were repeated 3 months later. We created mediation models using structural equation modeling (SEM) to assess the mediation effect of BRS on the association of PAS and other confounding variables with disability and pain at initial assessment and 3 months later. Results Resiliency does not mediate the association of psychological adaptability with physical limitations and pain intensity at baseline (P = .89 and .82 respectively) or 3 months after enrollment (P = .65 and .72 respectively). Conclusions Positive and protective factors promote beneficial resilience mechanisms that strengthen coping responses to pain and disability. In future studies we should either include more patients to improve power and provide more information about the health benefits of resilience or focus more on mood and self-efficacy on symptoms and limitations in patients with musculoskeletal illness. Level of evidence Prospective, longitudinal cohort study; Level II.
- Published
- 2019
14. Adverse Childhood Experiences Are Not Associated With Patient-reported Outcome Measures in Patients With Musculoskeletal Illness
- Author
-
Emily Z Boersma, Joost T.P. Kortlever, Janna S.E. Ottenhoff, David C. Laverty, David Ring, and Matthew D. Driscoll
- Subjects
030222 orthopedics ,medicine.medical_specialty ,business.industry ,Human factors and ergonomics ,Poison control ,General Medicine ,Suicide prevention ,Mental health ,Occupational safety and health ,03 medical and health sciences ,0302 clinical medicine ,Clinical Research ,Adverse Childhood Experiences ,Injury prevention ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Surgery ,Patient-reported outcome ,Patient Reported Outcome Measures ,030212 general & internal medicine ,Child ,business ,Psychiatry ,Depression (differential diagnoses) - Abstract
BACKGROUND: Adverse childhood experiences (ACEs) affect adult mental health and tend to contribute to greater symptoms of depression and more frequent suicide attempts. Given the relationship between symptoms of depression and patient-reported outcomes (PROs), adversity in childhood might be associated with PROs in patients seeking care for musculoskeletal problems, but it is not clear whether in fact there is such an association among patients seeking care in an outpatient, upper extremity orthopaedic practice. QUESTIONS/PURPOSES: (1) Are ACE scores independently associated with variation in physical limitations measured among patients seen by an orthopaedic surgeon? (2) Are ACE scores independently associated with variations in pain intensity? (3) What factors are associated with ACE scores when treated as a continuous variable or as a categorical variable? METHODS: We prospectively enrolled 143 adult patients visiting one of seven participating orthopaedic surgeons at three private and one academic orthopaedic surgery offices in a large urban area. We recorded their demographics and measured ACEs (using a validated 10-item binary questionnaire that measured physical, emotional, and sexual abuse in the first 18 years of life), magnitude of physical limitations, pain intensity, symptoms of depression, catastrophic thinking, and health anxiety. There were 143 patients with a mean age of 51 years, 62 (43%) of whom were men. In addition, 112 (78%) presented with a specific diagnosis and most (n = 79 [55%]) had upper extremity symptoms. We created one logistic and three linear regression models to test whether age, gender, race, marital status, having children, level of education, work status, insurance type, comorbidities, body mass index, smoking, site of symptoms, type of diagnosis, symptoms of depression, catastrophic thinking, and health anxiety were independently associated with (1) the magnitude of limitations; (2) pain intensity; (3) ACE scores on the continuum; and (4) ACE scores categorized (< 3 or ≥ 3). We calculated a priori that to detect a medium effect size with 90% statistical power and α set at 0.05, a sample of 136 patients was needed for a regression with five predictors if ACEs would account for ≥ 5% of the variability in physical function, and our complete model would account for 15% of the overall variability. To account for 5% incomplete responses, we enrolled 143 patients. RESULTS: We found no association between ACE scores and the magnitude of physical limitations measured by Patient-Reported Outcomes Measurement Information System Physical Function (p = 0.67; adjusted R(2) = 0.55). ACE scores were not independently associated with pain intensity (Pearson correlation [r] = 0.11; p = 0.18). Greater ACE scores were independently associated with diagnosed mental comorbidities both when analyzed on the continuum (regression coefficient [β] = 1.1; 95% confidence interval [CI], 0.32-1.9; standard error [SE] 0.41; p = 0.006) and categorized (odds ratio [OR], 3.3; 95% CI, 1.2-9.2; SE 1.7; p = 0.024), but not with greater levels of health anxiety (OR, 1.1; 95% CI, 0.90-1.3; SE 0.096; p = 0.44, C statistic = 0.71), symptoms of depression (ACE < 3 mean ± SD = 0.73 ± 1.4; ACE ≥ 3 = 1.0 ± 1.4; p = 0.29) or catastrophic thinking (ACE < 3 = 3.6 ± 3.5; ACE ≥ 3 = 4.9 ± 5.1; p = 0.88). CONCLUSIONS: ACEs may not contribute to greater pain intensity or magnitude of physical limitations unless they are accompanied by greater health anxiety or less effective coping strategies. Adverse events can contribute to anxiety and depression, but perhaps they sometimes lead to development of resilience and effective coping strategies. Future research might address whether ACEs affect symptoms and limitations in younger adult patients and patients with more severe musculoskeletal pathology such as major traumatic injuries. LEVEL OF EVIDENCE: Level II, prognostic study.
- Published
- 2018
15. High-Resolution Differentiation of Enteric Bacteria in Premature Infant Fecal Microbiomes Using a Novel rRNA Amplicon
- Author
-
Melissa J. Caimano, S. Coleman, Joerg Graf, E. Jackson, D. Fasulo, M. D. Driscoll, Adam P. Matson, D. Gratalo, and N. Ledala
- Subjects
DNA, Bacterial ,microbiome ,Computational biology ,Biology ,Microbiology ,Deep sequencing ,Feces ,03 medical and health sciences ,Enterobacteriaceae ,23S ribosomal RNA ,Intensive Care Units, Neonatal ,RNA, Ribosomal, 16S ,Virology ,Intensive care ,Humans ,Microbiome ,16S rRNA ,Phylogeny ,030304 developmental biology ,0303 health sciences ,Bacteria ,030306 microbiology ,Infant, Newborn ,Computational Biology ,High-Throughput Nucleotide Sequencing ,human infant ,Sequence Analysis, DNA ,Amplicon ,Ribosomal RNA ,16S ribosomal RNA ,neonates ,QR1-502 ,Gastrointestinal Microbiome ,RNA, Ribosomal ,long-read sequencing ,bacterial strains ,RRNA Operon ,microbial community ,Genome, Bacterial ,Infant, Premature ,Research Article - Abstract
Identifying and tracking microbial strains as microbiomes evolve are major challenges in the field of microbiome research. We utilized a new sequencing kit that combines DNA extraction with PCR amplification of a large region of the rRNA operon and downstream bioinformatic data analysis. Longitudinal microbiome samples of coadmitted twins from two different neonatal intensive care units (NICUs) were analyzed using an ∼2,500-base amplicon that spans the 16S and 23S rRNA genes and mapped to a new, custom 16S-23S rRNA database. Amplicon sequence variants (ASVs) inferred using DADA2 provided sufficient resolution for the differentiation of rRNA variants from closely related but not previously sequenced Klebsiella, Escherichia coli, and Enterobacter strains, among the first bacteria colonizing the gut of these infants after admission to the NICU. Distinct ASV groups (fingerprints) were monitored between coadmitted twins over time, demonstrating the potential to track the source and spread of both commensals and pathogens. The high-resolution taxonomy obtained from long amplicon sequencing enables the tracking of strains temporally and spatially as microbiomes are established in infants in the hospital environment.IMPORTANCE Achieving strain-level resolution is a major obstacle for source tracking and temporal studies of microbiomes. In this study, we describe a novel deep-sequencing approach that provides species- and strain-level resolution of the neonatal microbiome. Using Klebsiella, E. coli, and Enterobacter as examples, we could monitor their temporal dynamics after antibiotic treatment and in pairs of twins. The strain-level resolution, combined with the greater sequencing depth and decreased cost per read of PacBio Sequel 2, enables this advantageous source- and strain-tracking analysis method to be implemented widely across more complex microbiomes.
- Published
- 2021
16. Differences in obstetrical care and outcomes associated with the proportion of the obstetrician's shift completed
- Author
-
Lynn M. Yee, Paula McGee, Jennifer L. Bailit, Ronald J. Wapner, Michael W. Varner, John M. Thorp, Steve N. Caritis, Mona Prasad, Alan T.N. Tita, George R. Saade, Yoram Sorokin, Dwight J. Rouse, Sean C. Blackwell, Jorge E. Tolosa, G. Mallett, W. Grobman, M. Ramos-Brinson, A. Roy, L. Stein, P. Campbell, C. Collins, N. Jackson, M. Dinsmoor, J. Senka, K. Paychek, A. Peaceman, M. Talucci, M. Zylfijaj, Z. Reid, R. Leed, J. Benson, S. Forester, C. Kitto, S. Davis, M. Falk, C. Perez, K. Hill, A. Sowles, J. Postma, S. Alexander, G. Andersen, V. Scott, V. Morby, K. Jolley, J. Miller, B. Berg, K. Dorman, J. Mitchell, E. Kaluta, K. Clark, K. Spicer, S. Timlin, K. Wilson, L. Moseley, K. Leveno, M. Santillan, J. Price, K. Buentipo, V. Bludau, T. Thomas, L. Fay, C. Melton, J. Kingsbery, R. Benezue, H. Simhan, M. Bickus, D. Fischer, T. Kamon, D. DeAngelis, B. Mercer, C. Milluzzi, W. Dalton, T. Dotson, P. McDonald, C. Brezine, A. McGrail, C. Latimer, L. Guzzo, F. Johnson, L. Gerwig, S. Fyffe, D. Loux, S. Frantz, D. Cline, S. Wylie, J. Iams, M. Wallace, A. Northen, J. Grant, C. Colquitt, D. Rouse, W. Andrews, J. Moss, A. Salazar, A. Acosta, G. Hankins, N. Hauff, L. Palmer, P. Lockhart, D. Driscoll, L. Wynn, C. Sudz, D. Dengate, C. Girard, S. Field, P. Breault, F. Smith, N. Annunziata, D. Allard, J. Silva, M. Gamage, J. Hunt, J. Tillinghast, N. Corcoran, M. Jimenez, F. Ortiz, P. Givens, B. Rech, C. Moran, M. Hutchinson, Z. Spears, C. Carreno, B. Heaps, G. Zamora, J. Seguin, M. Rincon, J. Snyder, C. Farrar, E. Lairson, C. Bonino, W. Smith, K. Beach, S. Van Dyke, S. Butcher, E. Thom, M. Rice, Y. Zhao, V. Momirova, R. Palugod, B. Reamer, M. Larsen, C. Spong, S. Tolivaisa, and J.P. VanDorsten
- Subjects
Episiotomy ,Adult ,medicine.medical_specialty ,medicine.medical_treatment ,Psychological intervention ,Personnel Staffing and Scheduling ,Perineum ,Lacerations ,Article ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Obstetrics and gynaecology ,Pregnancy ,Intensive Care Units, Neonatal ,Physicians ,Medicine ,Humans ,030212 general & internal medicine ,Quality of Health Care ,030219 obstetrics & reproductive medicine ,business.industry ,Vaginal delivery ,Cesarean Section ,Obstetrics and Gynecology ,Workload ,Delivery mode ,Obstetric Labor Complications ,Obstetrics ,Logistic Models ,Emergency medicine ,Cohort ,Apgar Score ,Apgar score ,Female ,business - Abstract
Understanding and improving obstetrical quality and safety is an important goal of professional societies, and many interventions such as checklists, safety bundles, educational interventions, or other culture changes have been implemented to improve the quality of care provided to obstetrical patients. Although many factors contribute to delivery decisions, a reduced workload has addressed how provider issues such as fatigue or behaviors surrounding impending shift changes may influence the delivery mode and outcomes.The objective was to assess whether intrapartum obstetrical interventions and adverse outcomes differ based on the temporal proximity of the delivery to the attending's shift change.This was a secondary analysis from a multicenter obstetrical cohort in which all patients with cephalic, singleton gestations who attempted vaginal birth were eligible for inclusion. The primary exposure used to quantify the relationship between the proximity of the provider to their shift change and a delivery intervention was the ratio of time from the most recent attending shift change to vaginal delivery or decision for cesarean delivery to the total length of the shift. Ratios were used to represent the proportion of time completed in the shift by normalizing for varying shift lengths. A sensitivity analysis restricted to patients who were delivered by physicians working 12-hour shifts was performed. Outcomes chosen included cesarean delivery, episiotomy, third- or fourth-degree perineal laceration, 5-minute Apgar score of4, and neonatal intensive care unit admission. Chi-squared tests were used to evaluate outcomes based on the proportion of the attending's shift completed. Adjusted and unadjusted logistic models fitting a cubic spline (when indicated) were used to determine whether the frequency of outcomes throughout the shift occurred in a statistically significant, nonlinear pattern RESULTS: Of the 82,851 patients eligible for inclusion, 47,262 (57%) had ratio data available and constituted the analyzable sample. Deliveries were evenly distributed throughout shifts, with 50.6% taking place in the first half of shifts. There were no statistically significant differences in the frequency of cesarean delivery, episiotomy, third- or fourth-degree perineal lacerations, or 5-minute Apgar scores of4 based on the proportion of the shift completed. The findings were unchanged when evaluated with a cubic spline in unadjusted and adjusted logistic models. Sensitivity analyses performed on the 22.2% of patients who were delivered by a physician completing a 12-hour shift showed similar findings. There was a small increase in the frequency of neonatal intensive care unit admissions with a greater proportion of the shift completed (adjusted P=.009), but the findings did not persist in the sensitivity analysis.Clinically significant differences in obstetrical interventions and outcomes do not seem to exist based on the temporal proximity to the attending physician's shift change. Future work should attempt to directly study unit culture and provider fatigue to further investigate opportunities to improve obstetrical quality of care, and additional studies are needed to corroborate these findings in community settings.
- Published
- 2021
17. The Association Between Patient-Reported Outcome Measurement Scores and Preference for Specific Interventions
- Author
-
Emily Z Boersma, Gregg A. Vagner, Joost T.P. Kortlever, John McDonald, David Ring, Matthew D. Driscoll, and Michael D. Loeb
- Subjects
medicine.medical_specialty ,Health (social science) ,medical decision-making ,Leadership and Management ,Psychological intervention ,Prom ,clinician–patient relationship ,03 medical and health sciences ,0302 clinical medicine ,Intervention (counseling) ,medicine ,030212 general & internal medicine ,patient expectations ,Association (psychology) ,Research Articles ,030222 orthopedics ,lcsh:R5-920 ,communication ,business.industry ,Health Policy ,Preference ,Orthopedic surgery ,Physical therapy ,Patient-reported outcome ,business ,lcsh:Medicine (General) ,Cohort study - Abstract
To determine whether greater patient-reported symptom intensity and functional limitation influence expressed preferences for discretionary diagnostic and treatment interventions, we studied the association of patient factors and several Patient Reported Outcome Measure (PROM) scores with patient preferences for diagnostic and treatment interventions before and after the visit, a cross-sectional cohort study. One hundred and forty-three adult patients who completed several PROMs were asked their preferences for diagnostic and treatment interventions before and after a visit with an orthopedic surgeon. Patients with better physical function had fewer preferences for specific diagnostic interventions after the visit ( P = .02), but PROM scores had no association with preferences for treatment interventions before or after the visit. A greater percentage of patients expressed the preference for no diagnostic or treatment intervention after the visit with a physician than before (diagnostic intervention; 2.1% before vs 30% after the visit; P ≤ .001 and treatment intervention; 2.1% before vs 17% after the visit; P ≤ .001). This study suggests that physician expertise may be more reassuring to people with more adaptive mind sets.
- Published
- 2020
18. Tracking Closely Related Enteric Bacteria at High Resolution in Fecal Samples of Premature Infants Using a Novel rRNA Amplicon
- Author
-
Adam P. Matson, D. Gratalo, Joerg Graf, M. D. Driscoll, N. Ledala, Melissa J. Caimano, D. Fasulo, S. Coleman, and E. Jackson
- Subjects
Genetics ,Klebsiella ,biology ,23S ribosomal RNA ,Intensive care ,Microbiome ,Enterobacter ,Amplicon ,Ribosomal RNA ,biology.organism_classification ,Bacteria - Abstract
Identifying and tracking microbial strains as microbiomes evolve is a major challenge in the field of microbiome research. Longitudinal microbiome samples of co-admitted twins from two different neonatal intensive care units (NICUs) were analyzed using a ∼2,500 base amplicon that spans the 16S and 23S rRNA genes, and mapped to a new 16S-23S rRNA database. Amplicon Sequence Variants inferred using DADA2 provided sufficient resolution for differentiation of rRNA variants from closely related, but not previously sequenced Klebsiella, E. coli, and Enterobacter, among the first bacteria colonizing the gut of these infants after admission to the NICU. Distinct ASV groups (fingerprints) were followed between co-admitted twins over time, demonstrating the potential to track the source and spread of both commensals and pathogens.The high-resolution taxonomy obtained from long amplicon sequencing enable tracking of strains temporally and spatially as microbiomes are established in infants in the hospital environment.
- Published
- 2020
19. Improving Transfusion Safety in the Operating Room With a Barcode Scanning System Designed Specifically for the Surgical Environment and Existing Electronic Medical Record Systems: An Interrupted Time Series Analysis
- Author
-
Kimberly Donovan, Walter H. Dzik, William D. Driscoll, Hao Deng, Matthew Vanneman, Angela L Lang, Wilton C. Levine, Alyssa M Payette, Aditi Balakrishna, Xiaojun Xu, and Kent Eliason
- Subjects
Adult ,Operating Rooms ,Blood transfusion ,medicine.medical_treatment ,Audit ,Documentation ,Barcode ,Interrupted Time Series Analysis ,law.invention ,Workflow ,03 medical and health sciences ,Patient safety ,0302 clinical medicine ,030202 anesthesiology ,law ,Medicine ,Electronic Health Records ,Humans ,Blood Transfusion ,Software system ,Electronic Data Processing ,Medical Errors ,business.industry ,Medical record ,medicine.disease ,Quality Improvement ,Anesthesiology and Pain Medicine ,Medical emergency ,Guideline Adherence ,Patient Safety ,business ,030217 neurology & neurosurgery - Abstract
BACKGROUND Manual processes for verifying patient identification before blood transfusion and documenting this pretransfusion safety check are prone to errors, and compliance with manual systems is especially poor in urgent operating room settings. An automated, electronic barcode scanner system would be expected to improve pretransfusion verification and documentation. METHODS Audits were conducted of blood transfusion documentation under a manual paper system from January to October 2014. An electronic barcode scanning system was developed to streamline transfusion safety checking and automate documentation. This system was implemented in 58 operating rooms between October and December 2014, with follow-up compliance audits through December 2015. The association of barcode scanner implementation with transfusion documentation compliance was assessed using an interrupted time series analysis. Anesthesia providers were surveyed regarding their opinions on the electronic system. In mid-2016, the scanning system was modified to transfer from the Metavision medical record system to Epic OpTime. Follow-up analysis assessed performance of this system within Epic during 2017. RESULTS In an interrupted time series analysis, the proportion of units with compliant documentation was estimated to be 19.6% (95% confidence interval [CI], 10.7-25.6) the week before scanner implementation, and 74.4% (95% CI, 59.4-87.4) the week after implementation. There was a significant postintervention level change (odds ratio 10.80, 95% CI, 6.31-18.70; P < .001) and increase in slope (odds ratio 1.14 per 1-week increase, 95% CI, 1.11-1.17; P < .001). After implementation, providers chose to use the new electronic system for 98% of transfusions. Across the 2 years analyzed (15,997 transfusions), the electronic system detected 45 potential transfusion errors in 27 unique patients, and averted transfusion of 36 mismatched blood products into 20 unique patients. A total of 69%, 86%, and 88% of providers reported the electronic system improved patient safety, blood transfusion workflow, and transfusion documentation, respectively. When providers used the barcode scanner, no transfusion errors or reactions were reported. The scanner system was successfully transferred from Metavision to Epic without retraining staff or changing workflows. CONCLUSIONS A barcode-based system designed for easy integration to different commonly used anesthesia information management systems was implemented in a large urban academic hospital. The system allows a single user with the assistance of a software system to perform and document pretransfusion safety verification. The system improved transfusion documentation compliance, averted potential transfusion errors, and became the preferred method of blood transfusion safety checking.
- Published
- 2020
20. A National Survey of Complementary and Alternative Medicine Use for Treatment Among Asian-Americans
- Author
-
Susan D. Driscoll, Rhea Faye D Felicilda-Reynaldo, Cheryl L. Albright, and So Yung Choi
- Subjects
Complementary Therapies ,Male ,medicine.medical_specialty ,Epidemiology ,Alternative medicine ,Ethnic group ,Article ,03 medical and health sciences ,0302 clinical medicine ,Sex Factors ,Asian americans ,Medicine ,National Health Interview Survey ,Humans ,030212 general & internal medicine ,Cultural influence ,030505 public health ,Asian ,business.industry ,Asian Indian ,Public Health, Environmental and Occupational Health ,Age Factors ,Patient Acceptance of Health Care ,Educational attainment ,United States ,Socioeconomic Factors ,Female ,0305 other medical science ,business ,Demography - Abstract
BACKGROUND: Asian Americans (AAs) are more likely to use complementary and alternative medicine (CAM) compared to other race/ethnicities, yet previous studies have conflicting results. METHODS: The 2012 National Health Interview Survey data was analyzed to investigate AA’s (n=2,214) CAM use for treatment. AAs were divided into four subgroups: Chinese, Asian Indian, Filipino, and Other Asian. RESULTS: Only 9% of AAs reported using CAM for treatment, with 6% indicating CAM use specifically for chronic conditions. This could be a form of medical pluralism, a mixture of Eastern and Western health approaches. The “Other Asian” subgroup reported highest use of CAM for treatment. Significant predictors included age (≥65 years) and high educational attainment ((≥college degree). Sociodemographic factors were also significant predictors within Asian subgroups. CONCLUSION: Further investigation of this and other forms of medical pluralism among AAs are needed to explore potential cofounders and risks like underreporting, CAM schedules/dosages, cultural influences, and CAM’s impact on one’s health.
- Published
- 2020
21. Deep space optical communications (DSOC) beam expander design and engineering
- Author
-
Jason Schomacker, W. Klipstein, B. Zellers, J. Guregian, D. MacDonald, J. Carro, W. T. Roberts, and D. Driscoll
- Subjects
Physics ,Wavefront ,Afocal photography ,business.industry ,Astrophysics::Instrumentation and Methods for Astrophysics ,NASA Deep Space Network ,law.invention ,Telescope ,Optics ,law ,Physics::Space Physics ,Beam expander ,Astrophysics::Earth and Planetary Astrophysics ,business ,Adaptive optics ,Beam divergence ,Free-space optical communication - Abstract
Maintaining a stable and high quality laser wavefront is pivotal for efficient laser communications in deep space networks. In this presentation, we describe the design and expected optical and structural performance of the afocal beam expanding telescope for the NASA DSOC mission. This 22 cm aperture, 11x magnification telescope must survive the stresses of launch and maintain alignment through solar illumination, laser irradiance, thermal transients, and temperature extremes during the DSOC mission life from Earth to Mars. Structural-Thermal-OPtical (STOP) analysis predict very stable downlink wavefront error (< 122 nm RMS) and beam divergence (< 14.5 microradians). Furthermore, we present additional telescope link loss contributions that will be minimized through particulate contamination control, high spectral throughput, and polarization purity. Successful performance of this telescope will support NASA’s ongoing efforts to extended high data rate communications into deep space.
- Published
- 2020
22. A Critical look at the Evidence for and Against Epinephrine use in the toe - A Review
- Author
-
Dpm Kevin D. Driscoll and Dpm Mohammed K. Hassan
- Subjects
business.industry ,General Medicine ,Blood flow ,Anesthetic Effect ,Medical care ,Numerical digit ,body regions ,Epinephrine ,Phentolamine ,Anesthesia ,Block (telecommunications) ,Medicine ,medicine.symptom ,business ,Vasoconstriction ,medicine.drug - Abstract
When fingers or toes are injured, a digital block is commonly used to block the nerves to these digits, anesthetizing the digit to allow for more effective medical care.
- Published
- 2019
23. Accuracy of visual inspection performed by community health workers in cervical cancer screening
- Author
-
David Newman, Kathi Voege-Harvey, Susan D. Driscoll, and Ruth M. Tappen
- Subjects
medicine.medical_specialty ,genetic structures ,education ,Uterine Cervical Neoplasms ,Bivariate analysis ,Sensitivity and Specificity ,03 medical and health sciences ,0302 clinical medicine ,Health care ,Global health ,Humans ,Mass Screening ,Medicine ,Physical Examination ,Early Detection of Cancer ,Community Health Workers ,Vaginal Smears ,Colposcopy ,Cervical cancer ,030219 obstetrics & reproductive medicine ,Data collection ,medicine.diagnostic_test ,business.industry ,Obstetrics and Gynecology ,General Medicine ,medicine.disease ,Visual inspection ,stomatognathic diseases ,030220 oncology & carcinogenesis ,Meta-analysis ,Family medicine ,Female ,business - Abstract
Background Cervical cancer remains the leading cause of cancer and mortality in low-resource areas with healthcare personnel shortages. Visual inspection is a low-resource alternative method of cervical cancer screening in areas with limited access to healthcare. Objectives To assess accuracy of visual inspection performed by community health workers (CHWs) and licensed providers, and the effect of provider training on visual inspection accuracy. Search strategy Five databases and four websites were queried for studies published in English up to December 31, 2015. Derivations of "cervical cancer screening" and "visual inspection" were search terms. Selection criteria Visual inspection screening studies with provider definitions, colposcopy reference standards, and accuracy data were included. Data collection and analysis A priori variables were extracted by two independent reviewers. Bivariate linear mixed-effects models were used to compare visual inspection accuracy. Main results Provider type was a significant predictor of visual inspection sensitivity (P=0.048); sensitivity was 15 percentage points higher among CHWs than physicians (P=0.014). Components of provider training were significant predictors of sensitivity and specificity. Conclusions Community-based visual inspection programs using adequately trained CHWs could reduce barriers and expand access to screening, thereby decreasing cervical cancer incidence and mortality for women at highest risk and those living in remote areas with limited access to healthcare personnel.
- Published
- 2018
24. Getting Even or Getting Skewered: Piercing the Digital Veil of Anonymous Internet Speech as a Corporate Public Relations Tactic (Vengeance is Not Yours, Sayeth the Courts)
- Author
-
Samuel A. Terilli, Don W. Stacks, and Paul D. Driscoll
- Subjects
Communication. Mass media ,P87-96 ,Public relations. Industrial publicity ,HD59-59.6 - Abstract
Who said that? Asking that simple question when the vitriol flows across the Web is natural and human, especially when one’s secrets are publicly aired, or when the criticism stings, whether well founded or not. Defamation, interference with business and personal relationships, exposure of trade secrets, business plans and other less business-like information, gossip, and harassing speech by unknown persons with a screen name and Internet connection all occupy “the dark side of anonymous online speech.”1 Memorialized and amplified by technology, this dark speech takes on a much longer life and potency than mere rumors spread by word-of-mouth or the occasional letter campaign or pamphlet. The dark speech can traverse the globe, for years, eluding countervailing efforts to correct the record. Responding to the unknown sources of destructive or mischievous speech is the public relations equivalent of fighting a guerilla war. What then is the target to do? Demands to unmask the critics, malcontents, and digital provocateurs are not only understandable, they are logical and even necessary in some cases.
- Published
- 2010
25. Business Blogging In the Fog of Law: Traditional Agency Liability Principles and Less-Than-Traditional Section 230 Immunity in the Context of Blogs About Businesses
- Author
-
Samuel A. Terilli, Paul D. Driscoll, and Don W. Stacks
- Subjects
Communication. Mass media ,P87-96 ,Public relations. Industrial publicity ,HD59-59.6 - Abstract
Businesses of every size and type are involved in blogging – a novel and changing form of corporate communication that resides in an unsettled legal world. These blogs come in different varieties. Some are written by CEOs or other C-suite executives. Some are written by employees with a particular expertise. Some are directly supported, even hosted on the web, by the corporation. Some claim to be independent of any corporate influence, control or editing. Some are simply silent on those questions. Practitioners of businesses and public relations cannot safely treat any of these corporate blogs as fully-protected First Amendment speech. This study examines the legal issues stemming from various kinds of corporate blogs, analyzes the impact of legal issues on corporate and public relations blogging, and suggests a methodology for classifying various blogs and evaluating the risks presented by each.
- Published
- 2008
26. Decoupled Associative and Dissociative Processes in Strong yet Highly Dynamic Host–Guest Complexes
- Author
-
Max D. Driscoll, Sam Hay, Frank Biedermann, Eric A. Appel, David J. Wales, Oren A. Scherman, Jesus Barrio, and Dominique Hoogland
- Subjects
010405 organic chemistry ,Stereochemistry ,Chemistry ,Dissociation rate ,Kinetics ,High selectivity ,Supramolecular chemistry ,Viologen ,macromolecular substances ,General Chemistry ,ResearchInstitutes_Networks_Beacons/manchester_institute_of_biotechnology ,010402 general chemistry ,01 natural sciences ,Biochemistry ,Catalysis ,0104 chemical sciences ,Colloid and Surface Chemistry ,Reaction rate constant ,Computational chemistry ,Manchester Institute of Biotechnology ,medicine ,Ternary operation ,Binding selectivity ,medicine.drug - Abstract
Kinetics and thermodynamics in supramolecular systems are intimately linked, yet both are independently important for application in sensing assays and stimuli-responsive switching/self-healing of materials. Host-guest interactions are of particular interest in many water-based materials, sensing and drug delivery applications. Herein we investigate the binding dynamics of a variety of electron-rich aromatic moieties forming hetero-ternary complexes with the macrocycle cucurbit[8]uril (CB[8]) and an auxiliary guest, dimethyl viologen, with high selectivity and equilibrium binding constants (Keq up to 1014M−2). Using stopped-flow spectrofluorimetry, association rate constants were observed to approach the diffusion limit, and were found to be insensitive to the structure of the guest. Conversely, the dissociation rate constants of the ternary complexes varied dramatically with the guest structure and were correlated with the thermodynamic binding selectivity. Hence differing molecular features were found to contribute to the associative and dissociative processes, mimicking naturally occurring reactions and giving rise to a decoupling of these kinetic parameters. Moreover, we demonstrate the ability to exploit the phenomena and selectively perturb the associative process with external stimuli (e.g.viscosity and pressure). Significantly, these complexes exhibit increased binding equilibria with increasing pressure, carrying important implications in the application of theCB[8] ternary complex for the formation of hydrogels, as these gels exhibit unprecedented pressure-insensitive rheological properties. A high degree of flexibility therefore exists in the design of host-guest systems with tunable kinetic and thermodynamic parameters for tailor-made applications across a broad range of fields.
- Published
- 2017
27. Remote Surveillance Technologies: Realizing the Aim of Right Patient, Right Data, Right Time
- Author
-
Kyan C. Safavi, Jeanine P. Wiener-Kronish, and William D. Driscoll
- Subjects
Time Factors ,media_common.quotation_subject ,Cost-Benefit Analysis ,Clinical Sciences ,Wearable computer ,Information repository ,03 medical and health sciences ,0302 clinical medicine ,030202 anesthesiology ,Anesthesiology ,Health care ,medicine ,Humans ,Quality (business) ,Use case ,media_common ,Data Management ,Quality of Health Care ,Technology, Computing, and Simulation ,business.industry ,Neurosciences ,Information technology ,medicine.disease ,Variety (cybernetics) ,Anesthesiology and Pain Medicine ,Software deployment ,Remote Sensing Technology ,Medical emergency ,business ,030217 neurology & neurosurgery ,Medical Informatics - Abstract
The convergence of multiple recent developments in health care information technology and monitoring devices has made possible the creation of remote patient surveillance systems that increase the timeliness and quality of patient care. More convenient, less invasive monitoring devices, including patches, wearables, and biosensors, now allow for continuous physiological data to be gleaned from patients in a variety of care settings across the perioperative experience. These data can be bound into a single data repository, creating so-called data lakes. The high volume and diversity of data in these repositories must be processed into standard formats that can be queried in real time. These data can then be used by sophisticated prediction algorithms currently under development, enabling the early recognition of patterns of clinical deterioration otherwise undetectable to humans. Improved predictions can reduce alarm fatigue. In addition, data are now automatically queriable on a real-time basis such that they can be fed back to clinicians in a time frame that allows for meaningful intervention. These advancements are key components of successful remote surveillance systems. Anesthesiologists have the opportunity to be at the forefront of remote surveillance in the care they provide in the operating room, postanesthesia care unit, and intensive care unit, while also expanding their scope to include high-risk preoperative and postoperative patients on the general care wards. These systems hold the promise of enabling anesthesiologists to detect and intervene upon changes in the clinical status of the patient before adverse events have occurred. Importantly, however, significant barriers still exist to the effective deployment of these technologies and their study in impacting patient outcomes. Studies demonstrating the impact of remote surveillance on patient outcomes are limited. Critical to the impact of the technology are strategies of implementation, including who should receive and respond to alerts and how they should respond. Moreover, the lack of cost-effectiveness data and the uncertainty of whether clinical activities surrounding these technologies will be financially reimbursed remain significant challenges to future scale and sustainability. This narrative review will discuss the evolving technical components of remote surveillance systems, the clinical use cases relevant to the anesthesiologist's practice, the existing evidence for their impact on patients, the barriers that exist to their effective implementation and study, and important considerations regarding sustainability and cost-effectiveness.
- Published
- 2019
28. Do Patients Unconsciously Associate Suggestions for More-invasive Treatment with Better Care?
- Author
-
Thi T H Tran, Janna S.E. Ottenhoff, David Ring, Gregg A. Vagner, Joost T.P. Kortlever, and Matthew D. Driscoll
- Subjects
Adult ,Male ,medicine.medical_specialty ,Health Knowledge, Attitudes, Practice ,Adolescent ,Choice Behavior ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,Sex Factors ,Clinical Research ,medicine ,Humans ,Orthopedics and Sports Medicine ,Orthopedic Procedures ,030212 general & internal medicine ,Musculoskeletal Diseases ,Prospective Studies ,Intensive care medicine ,Aged ,Quality Indicators, Health Care ,030222 orthopedics ,business.industry ,Invasive treatments ,Patient Preference ,General Medicine ,Middle Aged ,Patient Acceptance of Health Care ,Cross-Sectional Studies ,Surgery ,Female ,business - Abstract
BACKGROUND: It seems common for patients to conceive of care in physical terms, such as medications, injections, and procedures rather than advice and support. Clinicians often encounter patients who seem to prefer more testing or invasive treatments than expertise supports. We wanted to determine whether patients unconsciously associate suggestions for invasive treatments with better care. QUESTIONS/PURPOSES: (1) Do patients have (A) an implicit preference and (B) an expressed preference for a physical intervention (such as a pill, an injection, or surgery) over supportive care (such as reassurance and education)? (2) What factors are independently associated with both an implicit and an expressed preference for a physical intervention over supportive care? (3) Is there a relationship between a patient’s implicit preference toward or away from a physical intervention and his/her expressed preference on that subject? METHODS: In this study, we approached 129 new patients in a large urban area visiting one of 13 participating surgeons divided among six upper and lower extremity specialist offices. After excluding four patients based on our exclusion criteria, 125 patients (97%) completed a survey of demographics and their expressed preference about receiving either physical treatment or support. Treatment was defined as any surgery, procedure, injection, or medication; support was defined as reassurance, conversation, and education, but no physical treatment. Patients then completed the Implicit Association Test (IAT) to evaluate implicit preferences toward treatment or support. Although other IATs have been validated in numerous studies, the IAT used in this study was specifically made for this study. Scores (D scores) range from -2 to 2, where 0 indicates no implicit preference, positive scores indicate a preference toward receiving a physical treatment is good care, and negative scores indicate a preference toward receiving supportive care is good care. According to the original IAT, break points for a slight (± 0.15 to 0.35), moderate (± 0.35 to 0.65), and strong preference (± 0.65 to 2) were selected conservatively according to psychological conventions for effect size. Patients’ mean age was 50 ± 15 years (range, 18–79 years) and 56 (45%) were men. The patients had a broad spectrum of upper and lower extremity musculoskeletal conditions, ranging from trigger finger to patellofemoral syndrome. RESULTS: We found a slight implicit association of good care with support (D = -0.17 ± 0.62; range, -2 to 1.2) and an expressed preference for physical treatment (mean score = 0.63 ± 2.0; range, -3 to 3). Patients who received both physical and supportive treatment had greater implicit preference for good care, meaning supportive care, than patients receiving physical care alone (β = -0.42; 95% CI, -0.73 to -0.11; p = 0.008; semipartial R(2) = 0.04; adjusted R(2) full model = 0.13). Gender was independently associated with a greater expressed preference for physical treatment, with men expressing this preference more than women (β = 1.0; 95% CI, 0.31–1.7; p = 0.005; semipartial R(2) = 0.06; adjusted R(2) full model = 0.08); receiving supportive treatment was independently associated with more expressed preference for support (β = -0.98; 95% CI, -1.7 to -0.23; p = 0.011; semipartial R(2) = 0.05). An expressed preference for treatment was not associated with implicit preference (β = 0.01; 95% CI, -0.04 to 0.06; p = 0.721). CONCLUSIONS: Although surgeons may sometimes feel pressured toward physical treatments, based on our results and cutoff values, the average patient with upper or lower extremity symptoms has a slight implicit preference for supportive treatment and would likely be receptive. LEVEL OF EVIDENCE: Level II, prognostic study.
- Published
- 2019
29. Multichannel Television Services
- Author
-
Michel Dupagne and Paul D. Driscoll
- Published
- 2018
30. Defining failed induction of labor
- Author
-
William A. Grobman, Jennifer Bailit, Yinglei Lai, Uma M. Reddy, Ronald J. Wapner, Michael W. Varner, John M. Thorp, Kenneth J. Leveno, Steve N. Caritis, Mona Prasad, Alan T.N. Tita, George Saade, Yoram Sorokin, Dwight J. Rouse, Sean C. Blackwell, Jorge E. Tolosa, G. Mallett, M. Ramos-Brinson, A. Roy, L. Stein, P. Campbell, C. Collins, N. Jackson, M. Dinsmoor, J. Senka, K. Paychek, A. Peaceman, M. Talucci, M. Zylfijaj, Z. Reid, R. Leed, J. Benson, S. Forester, C. Kitto, S. Davis, M. Falk, C. Perez, K. Hill, A. Sowles, J. Postma, S. Alexander, G. Andersen, V. Scott, V. Morby, K. Jolley, J. Miller, B. Berg, K. Dorman, J. Mitchell, E. Kaluta, K. Clark, K. Spicer, S. Timlin, K. Wilson, L. Moseley, M. Santillan, J. Price, K. Buentipo, V. Bludau, T. Thomas, L. Fay, C. Melton, J. Kingsbery, R. Benezue, H. Simhan, M. Bickus, D. Fischer, T. Kamon, D. DeAngelis, B. Mercer, C. Milluzzi, W. Dalton, T. Dotson, P. McDonald, C. Brezine, A. McGrail, C. Latimer, L. Guzzo, F. Johnson, L. Gerwig, S. Fyffe, D. Loux, S. Frantz, D. Cline, S. Wylie, J. Iams, M. Wallace, A. Northen, J. Grant, C. Colquitt, D. Rouse, W. Andrews, J. Moss, A. Salazar, A. Acosta, G. Hankins, N. Hauff, L. Palmer, P. Lockhart, D. Driscoll, L. Wynn, C. Sudz, D. Dengate, C. Girard, S. Field, P. Breault, F. Smith, N. Annunziata, D. Allard, J. Silva, M. Gamage, J. Hunt, J. Tillinghast, N. Corcoran, M. Jimenez, F. Ortiz, P. Givens, B. Rech, C. Moran, M. Hutchinson, Z. Spears, C. Carreno, B. Heaps, G. Zamora, J. Seguin, M. Rincon, J. Snyder, C. Farrar, E. Lairson, C. Bonino, W. Smith, K. Beach, S. Van Dyke, S. Butcher, E. Thom, M. Rice, Y. Zhao, P. McGee, V. Momirova, R. Palugod, B. Reamer, M. Larsen, C. Spong, S. Tolivaisa, and J.P. Van Dorsten
- Subjects
Adult ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Oxytocin ,Chorioamnionitis ,Article ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Oxytocics ,medicine ,Humans ,Rupture of membranes ,Labor, Induced ,030212 general & internal medicine ,030219 obstetrics & reproductive medicine ,Cesarean Section ,Vaginal delivery ,Obstetrics ,business.industry ,Cephalic presentation ,Postpartum Hemorrhage ,Obstetrics and Gynecology ,medicine.disease ,United States ,Labor induction ,Cohort ,Gestation ,Female ,business ,Cervical Ripening ,medicine.drug - Abstract
BACKGROUND: While there are well-accepted standards for the diagnosis of arrested active-phase labor, the definition of a "failed" induction of labor remains less certain. One approach to diagnosing a failed induction is based on the duration of the latent phase. However, a standard for the minimum duration that the latent phase of a labor induction should continue, absent acute maternal or fetal indications for cesarean delivery, remains lacking. OBJECTIVE: The objective of this study was to determine the frequency of adverse maternal and perinatal outcomes as a function of the duration of the latent phase among nulliparous women undergoing labor induction. METHODS: This study is based on data from an obstetric cohort of women delivering at 25 U.S. hospitals from 2008-2011. Nulliparous women who had a term singleton gestation in the cephalic presentation were eligible for this analysis if they underwent a labor induction. Consistent with prior studies, the latent phase was determined to begin once cervical ripening had ended, oxytocin was initiated and rupture of membranes (ROM) had occurred, and was determined to end once 5 cm dilation was achieved. The frequencies of cesarean delivery, as well as of adverse maternal (e.g., cesarean delivery, postpartum hemorrhage, chorioamnionitis) and perinatal outcomes (e.g., a composite frequency of either seizures, sepsis, bone or nerve injury, encephalopathy, or death), were compared as a function of the duration of the latent phase (analyzed with time both as a continuous measure and categorized in 3-hour increments). RESULTS: A total of 10,677 women were available for analysis. In the vast majority (96.4%) of women, the active phase had been reached by 15 hours. The longer the duration of a woman's latent phase, the greater her chance of ultimately undergoing a cesarean delivery (P
- Published
- 2018
- Full Text
- View/download PDF
31. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017
- Author
-
Lozano, R. Fullman, N. Abate, D. Abay, S.M. Abbafati, C. Abbasi, N. Abbastabar, H. Abd-Allah, F. Abdela, J. Abdelalim, A. Abdel-Rahman, O. Abdi, A. Abdollahpour, I. Abdulkader, R.S. Abebe, N.D. Abebe, Z. Abejie, A.N. Abera, S.F. Abil, O.Z. Aboyans, V. Abraha, H.N. Abrham, A.R. Abu-Raddad, L.J. Abu-Rmeileh, N.M. Abyu, G.Y. Accrombessi, M.M.K. Acharya, D. Acharya, P. Adamu, A.A. Adebayo, O.M. Adedeji, I.A. Adedoyin, R.A. Adekanmbi, V. Adetokunboh, O.O. Adhena, B.M. Adhikari, T.B. Adib, M.G. Adou, A.K. Adsuar, J.C. Afarideh, M. Afshari, M. Afshin, A. Agarwal, G. Aghayan, S.A. Agius, D. Agrawal, A. Agrawal, S. Ahmadi, A. Ahmadi, M. Ahmadieh, H. Ahmed, M.B. Ahmed, S. Akalu, T.Y. Akanda, A.S. Akbari, M.E. Akibu, M. Akinyemi, R.O. Akinyemiju, T. Akseer, N. Alahdab, F. Al-Aly, Z. Alam, K. Alam, T. Albujeer, A. Alebel, A. Alene, K.A. Al-Eyadhy, A. Alhabib, S. Ali, R. Alijanzadeh, M. Alizadeh-Navaei, R. Aljunid, S.M. Alkerwi, A. Alla, F. Allebeck, P. Allen, C.A. Almasi, A. Al-Maskari, F. Al-Mekhlafi, H.M. Alonso, J. Al-Raddadi, R.M. Alsharif, U. Altirkawi, K. Alvis-Guzman, N. Amare, A.T. Amenu, K. Amini, E. Ammar, W. Anber, N.H. Anderson, J.A. Andrei, C.L. Androudi, S. Animut, M.D. Anjomshoa, M. Ansari, H. Ansariadi, A. Ansha, M.G. Antonio, C.A.T. Anwari, P. Appiah, L.T. Aremu, O. Areri, H.A. Ärnlöv, J. Arora, M. Aryal, K.K. Asayesh, H. Asfaw, E.T. Asgedom, S.W. Asghar, R.J. Assadi, R. Ataro, Z. Atique, S. Atre, S.R. Atteraya, M.S. Ausloos, M. Avila-Burgos, L. Avokpaho, E.F.G.A. Awasthi, A. Quintanilla, B.P.A. Ayele, H.T. Ayele, Y. Ayer, R. Azarpazhooh, M.R. Azzopardi, P.S. Azzopardi-Muscat, N. Babalola, T.K. Babazadeh, A. Badali, H. Badawi, A. Balakrishnan, K. Bali, A.G. Banach, M. Banerjee, A. Banoub, J.A.M. Banstola, A. Barac, A. Barboza, M.A. Barker-Collo, S.L. Bärnighausen, T.W. Barrero, L.H. Barthelemy, C.M. Bassat, Q. Basu, A. Basu, S. Battista, R.J. Baune, B.T. Baynes, H.W. Bazargan-Hejazi, S. Bedi, N. Beghi, E. Behzadifar, M. Behzadifar, M. Béjot, Y. Bekele, B.B. Belachew, A.B. Belay, A.G. Belay, S.A. Belay, Y.A. Bell, M.L. Bello, A.K. Bennett, D.A. Bensenor, I.M. Benzian, H. Berhane, A. Berhe, A.K. Berman, A.E. Bernabe, E. Bernstein, R.S. Bertolacci, G.J. Beuran, M. Beyranvand, T. Bhala, N. Bhalla, A. Bhansali, A. Bhattarai, S. Bhaumik, S. Bhutta, Z.A. Biadgo, B. Biehl, M.H. Bijani, A. Bikbov, B. Bililign, N. Sayeed, M.S.B. Birlik, S.M. Birungi, C. Bisanzio, D. Biswas, T. Bitew, H. Bizuneh, H. Bjertness, E. Bobasa, E.M. Boufous, S. Bourne, R. Bozorgmehr, K. Bragazzi, N.L. Brainin, M. Brant, L.C. Brauer, M. Brazinova, A. Breitborde, N.J.K. Briant, P.S. Britton, G. Brugha, T. Bukhman, G. Busse, R. Butt, Z.A. Cahuana-Hurtado, L. Callender, C.S.K.H. Campos-Nonato, I.R. Rincon, J.C.C. Cano, J. Car, J. Car, M. Cárdenas, R. Carrero, J.J. Carter, A. Carvalho, F. Castañeda-Orjuela, C.A. Rivas, J.C. Castro, F. Causey, K. Çavlin, A. Cercy, K.M. Cerin, E. Chaiah, Y. Chalek, J. Chang, H.-Y. Chang, J.-C. Chattopadhyay, A. Chattu, V.K. Chaturvedi, P. Chiang, P.P.-C. Chin, K.L. Chisumpa, V.H. Chitheer, A. Choi, J.-Y.J. Chowdhury, R. Christensen, H. Christopher, D.J. Chung, S.-C. Cicuttini, F.M. Ciobanu, L.G. Cirillo, M. Claro, R.M. Claßen, T.K.D. Cohen, A.J. Collado-Mateo, D. Cooper, C. Cooper, L.T. Cornaby, L. Cortinovis, M. Costa, M. Cousin, E. Cromwell, E.A. Crowe, C.S. Cunningham, M. Daba, A.K. Dadi, A.F. Dandona, L. Dandona, R. Dang, A.K. Dargan, P.I. Daryani, A. Das, S.K. Das Gupta, R. Das Neves, J. Dasa, T.T. Dash, A.P. Davis, A.C. Davitoiu, D.V. Davletov, K. Dayama, A. De Courten, B. De Leo, D. Neve, J.W.D. De Steur, H. Degefa, M.G. Degenhardt, L. Degfie, T.T. Deiparine, S. Dellavalle, R.P. Demoz, G.T. Demtsu, B. Denova-Gutiérrez, E. Deribe, K. Dervenis, N. Dessie, G.A. Dey, S. Dharmaratne, S.D. Dhimal, M. Dicker, D. Dinberu, M.T. Ding, E.L. Djalalinia, S. Do, H.P. Dokova, K. Doku, D.T. Douwes-Schultz, D. Driscoll, T.R. Duan, L. Dubey, M. Dubljanin, E. Duken, E.E. Duncan, B.B. Duraes, A.R. Ebrahimpour, S. Edvardsson, D. El Bcheraoui, C. Eldrenkamp, E. El-Khatib, Z. Elyazar, I.R.F. Enayati, A. Endries, A.Y. Eshrati, B. Eskandarieh, S. Esteghamati, A. Esteghamati, S. Estep, K. Fakhar, M. Fakhim, H. Fanzo, J. Faramarzi, M. Fareed, M. Farhadi, F. Farid, T.A. Farinha, C.S.E.S. Farioli, A. Faro, A. Farvid, M.S. Farzadfar, F. Farzaei, M.H. Farzam, H. Fazaeli, A.A. Fazeli, M.S. Feigin, V.L. Feigl, A.B. Fekadu, W. Feldman, R. Fentahun, N. Fereshtehnejad, S.-M. Fernandes, E. Fernandes, J.C. Feyissa, G.T. Fijabi, D.O. Filip, I. Finegold, S. Finger, J.D. Fischer, F. Fitzmaurice, C. Flor, L.S. Foigt, N.A. Foreman, K.J. Frank, T.D. Franklin, R.C. Fukumoto, T. Fukutaki, K. Fuller, J.E. Fürst, T. Furtado, J.M. Gakidou, E. Gallus, S. Gankpe, F.G. Gansevoort, R.T. Garcia, A.C. Garcia-Basteiro, A.L. Garcia-Gordillo, M.A. Gardner, W.M. Gebre, A.K. Gebre, T. Gebregergs, G.B. Gebrehiwot, T.T. Gebremedhin, A.T. Gebremichael, B. Gebremichael, T.G. Gelano, T.F. Geleijnse, J.M. Geramo, Y.C.D. Getachew, S. Gething, P.W. Gezae, K.E. Ghadami, M.R. Ghadimi, R. Ghadiri, K. Ghasemi-Kasman, M. Ghiasvand, H. Ghimire, M. Ghoshal, A.G. Giampaoli, S. Gill, P.S. Gill, T.K. Giussani, G. Gnedovskaya, E.V. Goldberg, E.M. Goli, S. Gona, P.N. Goodridge, A. Gopalani, S.V. Gorman, T.M. Goto, A. Goulart, A.C. Goulart, B.N.G. Grada, A. Griswold, M.G. Grosso, G. Gugnani, H.C.C. Guillemin, F. Guimaraes, A.L.S. Guo, Y. Gupta, P.C. Gupta, R. Gupta, R. Gupta, T. Ha, G.H. Haagsma, J.A. Hachinski, V. Hafezi-Nejad, N. Bidgoli, H.H. Hagos, T.B. Haile, M.T. Hailegiyorgis, T.T. Hailu, G.B. Haj-Mirzaian, A. Haj-Mirzaian, A. Hamadeh, R.R. Hamidi, S. Hankey, G.J. Harb, H.L. Harikrishnan, S. Haririan, H. Haro, J.M. Hasan, M. Hassankhani, H. Hassen, H.Y. Havmoeller, R. Hawley, C.N. Hay, S.I. He, Y. Hedayatizadeh-Omran, A. Hegazy, M.I. Heibati, B. Heidari, B. Heidari, M. Hendrie, D. Henok, A. Heredia-Pi, I. Herteliu, C. Heydarpour, B. Heydarpour, F. Heydarpour, S. Hibstu, D.T. Híjar, M. Hoek, H.W. Hoffman, D.J. Hole, M.K. Homaie Rad, E. Hoogar, P. Horita, N. Hosgood, H.D. Hosseini, S.M. Hosseinzadeh, M. Hostiuc, M. Hostiuc, S. Hotez, P.J. Hoy, D.G. Hsairi, M. Hsiao, T. Hu, G. Huang, J.J. Hughes, C. Huynh, C.K. Igumbor, E.U. Ikeda, C.T. Ilesanmi, O.S. Iqbal, U. Irvani, S.S.N. Irvine, C.M.S. Islam, S.M.S. Islami, F. Ivers, R.Q. Izadi, N. Jacobsen, K.H. Jahangiry, L. Jahanmehr, N. Jain, S.K. Jakovljevic, M. Jalu, M.T. Jamal, A.A. James, S.L. Jassal, S.K. Javanbakht, M. Jayatilleke, A.U. Jeemon, P. Jha, R.P. Jha, V. Ji, J.S. Johnson, C.O. Johnson, S.C. Jonas, J.B. Jonnagaddala, J. Shushtari, Z.J. Joshi, A. Jozwiak, J.J. Jungari, S.B. Jürisson, M. Madhanraj, K. Kabir, Z. Kadel, R. Kahsay, A. Kahssay, M. Kalani, R. Kapil, U. Karami, M. Matin, B.K. Karanikolos, M. Karimi, N. Karimi, S.M. Karimi-Sari, H. Kasaeian, A. Kassa, D.H. Kassa, G.M. Kassa, T.D. Kassa, Z.Y. Kassebaum, N.J. Katikireddi, S.V. Kaul, A. Kawakami, N. Kazemi, Z. Karyani, A.K. Kazi, D.S. Prakash, K.C. Kebede, S. Keiyoro, P.N. Kemmer, L. Kemp, G.R. Kengne, A.P. Keren, A. Kesavachandran, C.N. Khader, Y.S. Khafaei, B. Khafaie, M.A. Khajavi, A. Khalid, N. Khalil, I.A. Khan, E.A. Khan, M.S. Khan, M.A. Khang, Y.-H. Khanna, T. Khater, M.M. Khatony, A. Khazaeipour, Z. Khazaie, H. Khoja, A.T. Khosravi, A. Khosravi, M.H. Khubchandani, J. Kiadaliri, A.A. Kiarie, H.W. Kibret, G.D. Kiirithio, D.N. Kim, D. Kim, J.Y. Kim, Y.-E. Kim, Y.J. Kimokoti, R.W. Kinfu, Y. Kinra, S. Kisa, A. Kissimova-Skarbek, K. Kissoon, N. Kivimäki, M. Kocarnik, J.M. Kochhar, S. Kokubo, Y. Kolola, T. Kopec, J.A. Kosek, M.N. Kosen, S. Koul, P.A. Koyanagi, A. Kravchenko, M.A. Krishan, K. Krohn, K.J. Defo, B.K. Kucuk Bicer, B. Kudom, A.A. Kulikoff, X.R. Kumar, G.A. Kumar, M. Kumar, P. Kutz, M.J. Kyu, H.H. Lachat, C. Lad, D.P. Lad, S.D. Lafranconi, A. Lagat, A.K. Lal, D.K. Lalloo, R. Lam, H. Lami, F.H. Lamichhane, P. Lan, Q. Lang, J.J. Lansingh, V.C. Lansky, S. Larson, H.J. Larsson, A.O. Laryea, D.O. Lassi, Z.S. Latifi, A. Lau, K.M.-M. Laxmaiah, A. Lazarus, J.V. Leasher, J.L. Lebedev, G. Ledesma, J.R. Lee, J.B. Lee, P.H. Leever, A.T. Leigh, J. Leinsalu, M. Leshargie, C.T. Leung, J. Lewycka, S. Li, S. Li, X. Li, Y. Liang, J. Liang, X. Liben, M.L. Lim, L.-L. Limenih, M.A. Linn, S. Liu, S. Liu, Y. Lodha, R. Logroscino, G. Lopez, A.D. Lorkowski, S. Lotufo, P.A. Lucchesi, L.R. Lyons, R.A. Macarayan, E.R.K. Mackay, M.T. Maddison, E.R. Madotto, F. Maghavani, D.P. Magis-Rodriguez, C. Mahotra, N.B. Majdan, M. Majdzadeh, R. Majeed, A. Malekzadeh, R. Malta, D.C. Mamun, A.A. Manda, A.-L. Mandarano-Filho, L.G. Mangalam, S. Manguerra, H. Mansournia, M.A. Mapoma, C.C. Maravilla, J.C. Marcenes, W. Marks, A. Martin, R.V. Martins, S.C.O. Martins-Melo, F.R. Martopullo, I. Mashamba-Thompson, T.P. Massenburg, B.B. Mathur, M.R. Maulik, P.K. Mazidi, M. McAlinden, C. McGrath, J.J. McKee, M. McMahon, B.J. Mehata, S. Mehndiratta, M.M. Mehrotra, R. Mehta, K.M. Mehta, V. Mejia-Rodriguez, F. Mekonen, T. Mekonnen, T.C.C. Meles, H.G. Melese, A. Melku, M. Memiah, P.T.N. Memish, Z.A. Mendoza, W. Mengistu, D.T. Mengistu, G. Mensah, G.A. Mensink, G.B.M. Mereta, S.T. Meretoja, A. Meretoja, T.J. Mestrovic, T. Mezgebe, H.B. Miazgowski, B. Miazgowski, T. Millear, A.I. Miller, T.R. Miller-Petrie, M.K. Milne, G.J. Mini, G.K. Minnig, S.P. Mirabi, P. Mirarefin, M. Mirrakhimov, E.M. Misganaw, A.T. Mitchell, P.B. Moazen, B. Moghadamnia, A.A. Mohajer, B. Mohammad, K.A. Mohammadi, M. Mohammadifard, N. Mohammadnia-Afrouzi, M. Mohammed, M.A. Mohammed, S. Mohan, M.B.V. Mohan, V. Mohebi, F. Moitra, M. Mokdad, A.H. Molokhia, M. Monasta, L. Montañez, J.C. Moosazadeh, M. Moradi, G. Moradi, M. Moradi-Lakeh, M. Moradinazar, M. Moraga, P. Morawska, L. Morgado-da-Costa, J. Morisaki, N. Morrison, S.D. Mosapour, A. Moschos, M.M. Mountjoy-Venning, W.C. Mouodi, S. Mousavi, S.M. Muche, A.A. Muchie, K.F. Mueller, U.O. Muhammed, O.S.S. Mukhopadhyay, S. Mullany, E.C. Muller, K. Mumford, J.E. Murhekar, M. Murthy, G.V.S. Murthy, S. Musa, J. Musa, K.I. Mustafa, G. Muthupandian, S. Nabhan, A.F. Nachega, J.B. Nagarajan, A.J. Nagel, G. Naghavi, M. Naheed, A. Nahvijou, A. Naidoo, K. Naik, G. Naik, N. Najafi, F. Naldi, L. Nam, H.S. Nangia, V. Nansseu, J.R. Nascimento, B.R. Nawaz, H. Neamati, N. Negoi, I. Negoi, R.I. Neupane, S. Newton, C.R.J. Ngalesoni, F.N. Ngunjiri, J.W. Nguyen, A. Nguyen, G. Nguyen, H. Nguyen, H.L.T. Nguyen, H.T. Nguyen, M. Nichols, E. Nigatu, S.G. Ningrum, D.N.A. Nirayo, Y.L. Nisar, M.I. Nixon, M.R. Nolutshungu, N. Nomura, M. Norheim, O.F. Noroozi, M. Norrving, B. Noubiap, J.J. Nouri, H.R. Shiadeh, M.N. Nowroozi, M.R. Nyasulu, P.S. Obermeyer, C.M. Ofori-Asenso, R. Ogah, O.S. Ogbo, F.A. Oh, I.-H. Okoro, A. Oladimeji, K.E. Oladimeji, O. Olagunju, A.T. Olagunju, T.O. Olivares, P.R. Olsen, H.E. Olusanya, B.O. Olusanya, J.O. Ong, K.L. Ong, S.K. Oommen, A.M. Opio, J.N. Oren, E. Oros, A. Ortega-Altamirano, D.D.V. Ortiz, A. Ortiz, J.R. Ortiz-Panozo, E. Ota, E. Otstavnov, S.S. Owolabi, M.O. Mahesh, P.A. Pakhale, S. Pakhare, A.P. Pan, W.-H. Pana, A. Panda, B.K. Panda-Jonas, S. Pandian, J.D. Papantoniou, N. Park, E.-K. Parry, C.D.H. Parsian, H. Patel, S. Pati, S. Patle, A. Patton, G.C. Paturi, V.R. Paudel, D. Paulson, K.R. Pearce, N. Peprah, E.K. Pereira, D.M. Perico, N. Pervaiz, A. Pesudovs, K. Petri, W.A. Petzold, M. Phillips, M.R. Pigott, D.M. Pillay, J.D. Pirsaheb, M. Pletcher, M. Pond, C.D. Postma, M.J. Pourshams, A. Poustchi, H. Prabhakaran, D. Prakash, S. Prasad, N. Purcell, C.A. Pyakurel, M. Qorbani, M. Quansah, R. Radfar, A. Rafay, A. Rafiei, A. Rahim, F. Rahimi, K. Rahimi-Movaghar, A. Rahimi-Movaghar, V. Rahman, M. Rahman, M.S. Rahman, M.H.U. Rahman, M.A. Rahman, S.U. Rai, R.K. Rajati, F. Rajsic, S. Ram, U. Rana, S.M. Ranabhat, C.L. Ranjan, P. Rasella, D. Rawaf, D.L. Rawaf, S. Razo-García, C. Reddy, K.S. Reiner, R.C. Reis, C. Reitsma, M.B. Remuzzi, G. Renzaho, A.M.N. Resnikoff, S. Reynales-Shigematsu, L.M. Rezaei, S. Rezaeian, S. Rezai, M.S. Riahi, S.M. Ribeiro, A.L.P. Rios-Blancas, M.J. Roba, K.T. Roberts, N.L.S. Roever, L. Ronfani, L. Roshandel, G. Rostami, A. Roth, G.A. Roy, A. Rubagotti, E. Ruhago, G.M. Sabde, Y.D. Sachdev, P.S. Saddik, B. Sadeghi, E. Safari, H. Safari, Y. Safari-Faramani, R. Safdarian, M. Safi, S. Safiri, S. Sagar, R. Sahebkar, A. Sahraian, M.A. Sajadi, H.S. Salam, N. Salama, J.S. Salamati, P. De Freitas Saldanha, R. Saleem, Z. Salimi, Y. Salimzadeh, H. Salomon, J.A. Salvi, S.S. Salz, I. Sambala, E.Z. Samy, A.M. Sanabria, J. Sanchez-Niño, M.D. Santos, I.S. Milicevic, M.M.S. Jose, B.P.S. Sardana, M. Sarker, A.R. Sarrafzadegan, N. Sartorius, B. Sarvi, S. Sathian, B. Satpathy, M. Savic, M. Sawant, A.R. Sawhney, M. Saxena, S. Saylan, M. Sayyah, M. Schaeffner, E. Schmidt, M.I. Schneider, I.J.C. Schöttker, B. Schutte, A.E. Schwebel, D.C. Schwendicke, F. Seedat, S. Sekerija, M. Sepanlou, S.G. Serván-Mori, E. Seyedmousavi, S. Shabaninejad, H. Shackelford, K.A. Shafieesabet, A. Shaheen, A.A. Shaikh, M.A. Shams-Beyranvand, M. Shamsi, M.B. Shamsizadeh, M. Sharafi, H. Sharafi, K. Sharif, M. Sharif-Alhoseini, M. Sharma, J. Sharma, R. Sharma, S.K. She, J. Sheikh, A. Shey, M.S. Shi, P. Shibuya, K. Shields, C. Shifa, G.T. Shiferaw, M.S. Shigematsu, M. Shiri, R. Shirkoohi, R. Shirude, S. Shishani, K. Shiue, I. Shokraneh, F. Shoman, H. Shrime, M.G. Shukla, S.R. Si, S. Siabani, S. Sibai, A.M. Siddiqi, T.J. Sigfusdottir, I.D. Silpakit, N. Silva, D.A.S. Silva, J.P. Da Silva, N.T. Silveira, D.G.A. Singh, J.A. Singh, N.P. Singh, O.P. Singh, P.K. Singh, V. Sinha, D.N. Skiadaresi, E. Sliwa, K. Smith, A.E. Smith, M. Filho, A.M.S. Sobaih, B.H. Sobhani, S. Soljak, M. Soofi, M. Soosaraei, M. Sorensen, R.J.D. Soriano, J.B. Soshnikov, S. Soyiri, I.N. Spinelli, A. Sposato, L.A. Sreeramareddy, C.T. Srinivasan, R.G. Srinivasan, V. Stanaway, J.D. Starodubov, V.I. Stathopoulou, V. Steckling, N. Stein, D.J. Stewart, L.G. Stockfelt, L. Stokes, M.A. Straif, K. Sudaryanto, A. Sufiyan, M.B. Sunguya, B.F. Sur, P.J. Sutradhar, I. Sykes, B.L. Sylaja, P.N. Sylte, D.O. Szoeke, C.E.I. Tabarés-Seisdedos, R. Tabuchi, T. Tadakamadla, S.K. Tamirat, K.S. Tandon, N. Tanser, F.C. Tassew, A.A. Tassew, S.G. Tavakkoli, M. Taveira, N. Tawye, N.Y. Tehrani-Banihashemi, A. Tekalign, T.G. Tekle, M.G. Temesgen, H. Temsah, M.-H. Temsah, O. Terkawi, A.S. Teshale, M.Y. Teshome, D.F. Tessema, B. Teweldemedhin, M. Thakur, J.S. Thankappan, K.R. Theis, A. Thirunavukkarasu, S. Thomas, L.A. Thomas, N. Thomson, A.J. Thrift, A.G. Tilahun, B. To, Q.G. Tobe-Gai, R. Tonelli, M. Topor-Madry, R. Torre, A.E. Tortajada-Girbés, M. Tovani-Palone, M.R. Towbin, J.A. Tran, B.X. Tran, K.B. Tran, T.T. Tripathy, S.P. Troeger, C.E. Truelsen, T.C. Tsadik, A.G. Car, L.T. Tuzcu, E.M. Tymeson, H.D. Ukwaja, K.N. Ullah, I. Updike, R.L. Usman, M.S. Uthman, O.A. Vaduganathan, M. Vaezi, A. Vaidya, G. Valdez, P.R. Van Donkelaar, A. Varavikova, E. Vasankari, T.J. Venketasubramanian, N. Vidavalur, R. Villafaina, S. Violante, F.S. Vladimirov, S.K. Vlassov, V. Vollmer, S. Vollset, S.E. Vos, T. Vosoughi, K. Vujcic, I.S. Wagner, G.R. Wagnew, F.S. Waheed, Y. Walson, J.L. Wang, Y. Wang, Y.-P. Wassie, M.M. Weiderpass, E. Weintraub, R.G. Weiss, J. Weldegebreal, F. Weldegwergs, K.G. Werdecker, A. Werkneh, A.A. West, T.E. Westerman, R. Whisnant, J.L. Whiteford, H.A. Widecka, J. Widecka, K. Wijeratne, T. Wilner, L.B. Winkler, A.S. Wiyeh, A.B. Wiysonge, C.S. Wolde, H.F. Wolfe, C.D.A. Wu, S. Xavier, D. Xu, G. Xu, R. Yadollahpour, A. Jabbari, S.H.Y. Yakob, B. Yamada, T. Yan, L.L. Yano, Y. Yaseri, M. Yasin, Y.J. Ye, P. Yearwood, J.A. Yeshaneh, A. Yimer, E.M. Yip, P. Yirsaw, B.D. Yisma, E. Yonemoto, N. Yonga, G. Yoon, S.-J. Yotebieng, M. Younis, M.Z. Yousefifard, M. Yu, C. Zaman, S.B. Zamani, M. Zare, Z. Zavala-Arciniega, L. Zegeye, D.T. Zegeye, E.A. Zeleke, A.J. Zendehdel, K. Zerfu, T.A. Zhang, A.L. Zhang, X. Zhou, M. Zhu, J. Zimsen, S.R.M. Zodpey, S. Zoeckler, L. Zucker, I. Zuhlke, L.J.J. Lim, S.S. Murray, C.J.L. GBD 2017 SDG Collaborators
- Abstract
Background: Efforts to establish the 2015 baseline and monitor early implementation of the UN Sustainable Development Goals (SDGs) highlight both great potential for and threats to improving health by 2030. To fully deliver on the SDG aim of “leaving no one behind”, it is increasingly important to examine the health-related SDGs beyond national-level estimates. As part of the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD 2017), we measured progress on 41 of 52 health-related SDG indicators and estimated the health-related SDG index for 195 countries and territories for the period 1990–2017, projected indicators to 2030, and analysed global attainment. Methods: We measured progress on 41 health-related SDG indicators from 1990 to 2017, an increase of four indicators since GBD 2016 (new indicators were health worker density, sexual violence by non-intimate partners, population census status, and prevalence of physical and sexual violence [reported separately]). We also improved the measurement of several previously reported indicators. We constructed national-level estimates and, for a subset of health-related SDGs, examined indicator-level differences by sex and Socio-demographic Index (SDI) quintile. We also did subnational assessments of performance for selected countries. To construct the health-related SDG index, we transformed the value for each indicator on a scale of 0–100, with 0 as the 2·5th percentile and 100 as the 97·5th percentile of 1000 draws calculated from 1990 to 2030, and took the geometric mean of the scaled indicators by target. To generate projections through 2030, we used a forecasting framework that drew estimates from the broader GBD study and used weighted averages of indicator-specific and country-specific annualised rates of change from 1990 to 2017 to inform future estimates. We assessed attainment of indicators with defined targets in two ways: first, using mean values projected for 2030, and then using the probability of attainment in 2030 calculated from 1000 draws. We also did a global attainment analysis of the feasibility of attaining SDG targets on the basis of past trends. Using 2015 global averages of indicators with defined SDG targets, we calculated the global annualised rates of change required from 2015 to 2030 to meet these targets, and then identified in what percentiles the required global annualised rates of change fell in the distribution of country-level rates of change from 1990 to 2015. We took the mean of these global percentile values across indicators and applied the past rate of change at this mean global percentile to all health-related SDG indicators, irrespective of target definition, to estimate the equivalent 2030 global average value and percentage change from 2015 to 2030 for each indicator. Findings: The global median health-related SDG index in 2017 was 59·4 (IQR 35·4–67·3), ranging from a low of 11·6 (95% uncertainty interval 9·6–14·0) to a high of 84·9 (83·1–86·7). SDG index values in countries assessed at the subnational level varied substantially, particularly in China and India, although scores in Japan and the UK were more homogeneous. Indicators also varied by SDI quintile and sex, with males having worse outcomes than females for non-communicable disease (NCD) mortality, alcohol use, and smoking, among others. Most countries were projected to have a higher health-related SDG index in 2030 than in 2017, while country-level probabilities of attainment by 2030 varied widely by indicator. Under-5 mortality, neonatal mortality, maternal mortality ratio, and malaria indicators had the most countries with at least 95% probability of target attainment. Other indicators, including NCD mortality and suicide mortality, had no countries projected to meet corresponding SDG targets on the basis of projected mean values for 2030 but showed some probability of attainment by 2030. For some indicators, including child malnutrition, several infectious diseases, and most violence measures, the annualised rates of change required to meet SDG targets far exceeded the pace of progress achieved by any country in the recent past. We found that applying the mean global annualised rate of change to indicators without defined targets would equate to about 19% and 22% reductions in global smoking and alcohol consumption, respectively; a 47% decline in adolescent birth rates; and a more than 85% increase in health worker density per 1000 population by 2030. Interpretation: The GBD study offers a unique, robust platform for monitoring the health-related SDGs across demographic and geographic dimensions. Our findings underscore the importance of increased collection and analysis of disaggregated data and highlight where more deliberate design or targeting of interventions could accelerate progress in attaining the SDGs. Current projections show that many health-related SDG indicators, NCDs, NCD-related risks, and violence-related indicators will require a concerted shift away from what might have driven past gains—curative interventions in the case of NCDs—towards multisectoral, prevention-oriented policy action and investments to achieve SDG aims. Notably, several targets, if they are to be met by 2030, demand a pace of progress that no country has achieved in the recent past. The future is fundamentally uncertain, and no model can fully predict what breakthroughs or events might alter the course of the SDGs. What is clear is that our actions—or inaction—today will ultimately dictate how close the world, collectively, can get to leaving no one behind by 2030. Funding: Bill & Melinda Gates Foundation. © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
- Published
- 2018
32. Arthroscopic Transosseous Bony Bankart Repair
- Author
-
Stephen J. Snyder, Matthew D. Driscoll, and Joseph P. Burns
- Subjects
Orthopedic surgery ,medicine.medical_specialty ,business.industry ,Glenohumeral instability ,medicine.medical_treatment ,Bankart Fractures ,Surgery ,medicine ,Orthopedics and Sports Medicine ,Bankart repair ,business ,RD701-811 ,Reduction (orthopedic surgery) ,Suture anchors - Abstract
Restoration of glenoid bony integrity is critical to minimizing the risk of recurrence and re-creating normal kinematics in the setting of anterior glenohumeral instability. We present an arthroscopic suture anchor–based technique for treating large bony Bankart fractures in which the fragment is secured to the intact glenoid using mattress sutures placed through the bony fragment and augmented with soft-tissue repair proximal and distal to the bony lesion. This straightforward technique has led to excellent fragment reduction and good outcomes in our experience.
- Published
- 2015
33. Medial Malleolar Screw Versus Tension-band Plate Hemiepiphysiodesis for Ankle Valgus in the Skeletally Immature
- Author
-
Matthew D. Driscoll, Elroy Sullivan, Allison Scott, and Judith Linton
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,Radiography ,Arthrodesis ,medicine.medical_treatment ,Bone Screws ,Salter-Harris Fractures ,Bone plate ,Humans ,Medicine ,Fluoroscopy ,Orthopedics and Sports Medicine ,Musculoskeletal Diseases ,Tibia ,Child ,Device Removal ,Retrospective Studies ,biology ,medicine.diagnostic_test ,business.industry ,Tarsal Bones ,General Medicine ,medicine.disease ,biology.organism_classification ,Surgery ,Joint Deformities, Acquired ,Valgus ,Treatment Outcome ,medicine.anatomical_structure ,Surgery, Computer-Assisted ,Salter–Harris fracture ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Equipment Failure ,Female ,Ankle ,business ,Bone Plates ,Epiphyses ,Ankle Joint ,Follow-Up Studies - Abstract
Background Ankle valgus is frequently encountered in skeletally immature patients in association with a variety of musculoskeletal disorders. Guided growth with temporary medial malleolar transphyseal screw (MMS) hemiepiphysiodesis is an established surgical treatment capable of correcting the angular deformity, but is often complicated by symptomatic screw head prominence and difficult hardware removal. Tension-band plate (TBP) hemiepiphysiodesis has recently been advocated as an alternative; however, the relative efficacy of these 2 techniques has not been directly investigated. Thus, the purpose of this study was to compare MMS and TBP in treatment of pediatric ankle valgus deformity. Methods Medical records and radiographs of all patients undergoing distal tibial medial hemiepiphysiodesis for ankle valgus between January 1, 2005 and November 1, 2010 at a pediatric orthopaedic specialty hospital were retrospectively reviewed. Radiographs obtained preoperatively and at 6-month intervals postoperatively were reviewed and the tibiotalar angle was measured. Patient age, sex, underlying diagnosis, concurrent surgical procedures, surgical and postoperative complications, and the presence or absence of symptomatic hardware complaints were documented. Results Sixty ankles in 42 patients met the inclusion criteria, with adequate radiographs and minimum postoperative follow-up of 12 months (mean: 34 mo). Thirty-five ankles were treated with MMS, and 25 with TBP. Good mean correction of the tibiotalar angle was achieved in both groups (MMS: pre-77.1 degrees to post-87.8 degrees over 25.2 mo; TBP: pre-81.3 to post-87.6 over 20.0 mo). The mean rate of correction was faster in ankles treated with MMS than TBP, but differences did not reach statistical significance (0.55 vs. 0.36 degrees/mo, respectively; P=0.057). Complications included 6 hardware-related surgical complications in MMS ankles (17.1%) and 1 in TBP ankles (4.0%). The incidence of symptomatic hardware complaints was low in both groups (MMS, 5.7%; TBP, 0%). Conclusions Both MMS and TBP techniques can result in successful correction of ankle valgus in the growing child. Although the rate of deformity correction may be faster with MMS, TBP seems to be associated with fewer hardware-related complications. This information may aid the clinician in selecting the surgical option most appropriate for each individual patient. Level of evidence Level II-retrospective study.
- Published
- 2014
34. A quantitative fluorescence-based steady-state assay of DNA polymerase
- Author
-
Max D. Driscoll, Julius Rentergent, and Sam Hay
- Subjects
steady‐state ,DNA polymerase ,DNA polymerase II ,DNA quantification ,DNA, Single-Stranded ,DNA-Directed DNA Polymerase ,Biochemistry ,Fluorescence ,enzyme kinetics ,PicoGreen ,Nick translation ,Promoter Regions, Genetic ,Molecular Biology ,Polymerase ,Enzyme Assays ,Klenow fragment ,DNA clamp ,biology ,Multiple displacement amplification ,Original Articles ,Cell Biology ,Michaelis–Menten ,polymerase ,Real-time polymerase chain reaction ,biology.protein ,Original Article - Abstract
Fluorescent dyes that bind DNA have been demonstrated as a useful alternative to radionucleotides for the quantification of DNA and the in vitro measurement of the activity of DNA polymerases and nucleases. However, this approach is generally used in a semi-quantitative way to determine relative rates of reaction. In this report, we demonstrate a method for the simultaneous quantification of DNA in both its single-strand and double-strand forms using the dye PicoGreen. This approach is used in a steady-state assay of DNA polymerase Klenow fragment exo(−), where we determine kcat and Km values for the DNA polymerase that are in excellent agreement with literature values.
- Published
- 2014
35. Analysis of Hospitalization and Readmissions after CAR T Cell Therapy
- Author
-
Dusan Handiziar, Matthiew Frigault, Elizabeth O'Donnell, Milcho Nikolov, Kyan C. Safavi, William D. Driscoll, Hao Deng, Noopur Raje, and Andrew Yee
- Subjects
medicine.medical_specialty ,Immunology ,030226 pharmacology & pharmacy ,Biochemistry ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,law ,Acute lymphocytic leukemia ,Internal medicine ,Medicine ,biology ,business.industry ,C-reactive protein ,Cell Biology ,Hematology ,medicine.disease ,Institutional review board ,Intensive care unit ,Confidence interval ,Clinical trial ,030220 oncology & carcinogenesis ,biology.protein ,Chimeric Antigen Receptor T-Cell Therapy ,business ,Progressive disease - Abstract
Background: Chimeric antigen receptor (CAR) T-cell therapy is a rapidly emerging form of treatment for hematologic malignancies including lymphoma, multiple myeloma, and leukemia. Hospitalizations and readmissions after CAR T-cell therapy have not been systematically studied. A better understanding of hospital utilization patterns could inform design of clinical trials, advanced planning of hospitalizations, timing of discharge, and frequency and type of outpatient follow-up. Methods: We conducted a retrospective analysis of all patients admitted to the Massachusetts General Hospital for CAR T-cell therapy between 3/2016 and 3/2018. The primary outcome was hospital readmission within 30 days following discharge from CAR-T treatment visit. Secondary outcomes were ICU admission and inpatient mortality. Exploratory analyses were also conducted to determine whether patient age, length of initial hospitalization, laboratory measurements including ferritin and C-reactive protein (CRP), and tocilizumab exposure were associated with 30-day readmission. Summary statistics were reported by disease types, CAR-T products, and the primary and secondary outcomes using appropriate statistical functions. Comparison of laboratory values (ferritin and CRP) between the index admission (CAR T infusion) and first-readmission visits were analyzed using random intercept linear mixed effects models. Pairwise comparisons regarding mean difference of laboratory measurements during index admission and 30-day readmission/non-readmission were conducted and 95% confidence intervals reported. Bonferroni method was used for p-value adjustment (number of comparison groups = 4). This study was approved by the Partners Healthcare Institutional Review Board. Results: Forty-two patients were treated with CAR T-cells between 3/2016 and 3/2018. Thirty-six patients had non-Hodgkins lymphoma (NHL), 1 acute lymphoblastic leukemia, 1 chronic lymphocytic leukemia, and 4 multiple myeloma. Eight (19%) received the standard of care product, axicabtagene ciloleucel and all others were treated on a clinical trial with an investigational product. Median age at first treatment was 62.2 years old. Twenty-nine patients were male and 13 female. Fourteen patients (33.3%) experienced readmission within 30 days following discharge from CAR T infusion hospitalization. Twelve patients (29%) were readmitted within the first 14 days and 20 patients (47.6%) were readmitted to the hospital within 90 days of discharge (Figure 1). Patient age was not associated with 30-day readmission (P=0.642). Thirty-four (81%) patients received one CAR-T treatment and 8 (19%) received 2 treatments. Among those who received a second CAR-T treatment, 4 (50%) experienced 30-day readmission. Overall, 3 (7%) patients required transfer to the ICU (1 patient after both CAR T infusions) and two patients with NHL died during their first CAR T treatment admission. One patient died of progressive disease 44 days post-CAR T and the other died of disseminated candidemia 18 day post-CAR T. Our mixed effects model showed that median ferritin level was significantly elevated during the 30-day readmission visit as compared to initial CAR T infusion visit (1526.5 vs 1005.5 ug/L, difference in mean = 1088.5, 95% CI: 437.4 to 1739.6, adjusted P = 0.009). CAR T infusion visit ferritin levels did not differ among patients who were readmitted within 30 days and those who were not (1143.0 vs 1005.5 ug/L, P = 1.0). For readmissions which occurred after 30 days, we did not find a statistically significant increase in ferritin levels (P = 0.809). We did not find an association between initial length of hospitalization, CRP levels, and tocilizumab usage and early readmissions (all P-values > 0.05). Conclusions: CAR T-cell therapy is a promising evolving therapy for the treatment of relapsed, refractory hematologic malignancies. Further evaluation of pooled data may allow for early identification of patterns of deterioration which may limit premature hospital discharge, early readmission, and therapy-associated mortality. Figure 1. Figure 1. Disclosures No relevant conflicts of interest to declare.
- Published
- 2018
36. Processing and characterization of Sr2−xVMoO6−δ double perovskites
- Author
-
N. Childs, Richard J.H. Smith, D. Driscoll, Paul Gannon, Stephen W. Sofie, Roberta Amendola, and A.J. Weisentein
- Subjects
Materials science ,Reducing atmosphere ,Analytical chemistry ,Pellets ,Mineralogy ,Vanadium ,chemistry.chemical_element ,Sintering ,Condensed Matter Physics ,chemistry.chemical_compound ,X-ray photoelectron spectroscopy ,chemistry ,Electrical resistivity and conductivity ,Scheelite ,Phase (matter) ,General Materials Science - Abstract
In this study, the analysis and characterization of the processing and sintering of Sr 2− x VMoO 6− δ perovskites, where x = 0.0, 0.1 and 0.2, was investigated with application potential in high temperature fuel cell electrodes and electro-catalysts. Sr 2− x VMoO 6− δ substrates were sintered in a reducing (5%H 2 95%N 2 ) atmosphere at 1100 °C, 1200 °C, and 1300 °C. The X-ray diffraction patterns indicate that the double perovskite is the primary phase for Sr 2− x VMoO 6− δ pellets sintered at 1200 °C and 1300 °C for 20 h; however, these pellets show a secondary phase of SrMoO 4− δ . X-ray photoelectron spectroscopy revealed a deficiency of vanadium on the pellet surfaces, in which samples yielded surface vanadium concentrations of less than 5%. The vanadium inhomogeneity can be explained by the formation of the SrMoO 4− δ scheelite phase (ABO 4 ) due to oxygen exposure on the surface of the pellets, which indicates inward vanadium migration to the bulk, and was exhibited in redox cycling. Sr 2− x VMoO 6− δ pellets sintered at 1300 °C showed the lowest resistivity at both SOFC operating temperature (800 °C) and room temperature. The resistivity tests also show a semiconductor to metallic transition for all double perovskites, from heating up to 800 °C to cooling down to room temperature in a reducing atmosphere, related to the reduction of Mo 6+ to Mo 4+ .
- Published
- 2013
37. Marrow Stimulation Improves Meniscal Healing at Early Endpoints in a Rabbit Meniscal Injury Model
- Author
-
Daniel C. Jupiter, Brett N. Robin, Masafumi Horie, Binu Tharakan, Matthew D. Driscoll, Robert E. Reeve, H. Wayne Sampson, and Zachary T. Hubert
- Subjects
medicine.medical_specialty ,Time Factors ,Arthroplasty, Subchondral ,medicine.medical_treatment ,Menisci, Tibial ,Chondrocytes ,Bone Marrow ,medicine ,Animals ,Regeneration ,Marrow stimulation ,Single-Blind Method ,Orthopedics and Sports Medicine ,Clinical significance ,Wound Healing ,Staining and Labeling ,business.industry ,Growth factor ,Fibroblasts ,Arthroplasty ,Tibial Meniscus Injuries ,Staining ,Surgery ,medicine.anatomical_structure ,Models, Animal ,Cytokines ,Intercellular Signaling Peptides and Proteins ,Immunohistochemistry ,Female ,Rabbits ,business ,Medial meniscus - Abstract
Purpose To critically evaluate the effect of marrow stimulation (MS) on the extent of healing and the local biological environment after meniscal injury in ligamentously stable knees in a rabbit model. Methods A reproducible 1.5-mm cylindrical defect was created in the avascular portion of the anterior horn of the medial meniscus bilaterally in 18 New Zealand White rabbits (36 knees). In right knees (MS knees), a 2.4-mm Steinman pin was drilled into the apex of the femoral intercondylar notch and marrow contents were observed spilling into the joint. Left knees served as controls. Rabbits were killed in 3 groups (n = 6 rabbits each) at 1, 4, and 12 weeks with meniscal harvest and blinded histomorphometric and histologic evaluation using an established 3-component tissue quality score (range, 0 to 6). One-week specimens were also evaluated for the presence of proregenerative cytokines using immunohistochemistry. Results The mean proportion of the avascular zone defect bridged by reparative tissue was greater in MS knees than in controls at each endpoint (1 week, 55% v 30%, P = .02; 4 weeks, 71% v 53%, P = .047; 12 weeks, 96% v 77%, P = .16). Similarly, there was a consistent trend toward superior tissue quality scores in knees treated with MS compared with controls (1 week, 1.8 v 0.3, P = .03; 4 weeks, 4.3 v 2.8, P = .08; 12 weeks, 5.9 v 4.5, P = .21). No statistically significant differences, however, were observed at the 12-week endpoint. Increased staining for insulin-like growth factor I, transforming growth factor-β, and platelet-derived growth factor was observed in regenerated tissue, compared with native meniscal tissue, in all specimens at 1 week. Staining density for all growth factors was similar, however, in reparative tissue of MS and control knees. Conclusions The results of this study suggest that marrow stimulation leads to modest improvements in quality and quantity of reparative tissue bridging a meniscal defect, particularly during the early recovery period. Clinical Relevance Clinical evaluation of marrow stimulation techniques designed to enhance healing in isolated meniscus repair surgery may be indicated.
- Published
- 2013
38. Structural characterization of CYP144A1 - a cytochrome P450 enzyme expressed from alternative transcripts in Mycobacterium tuberculosis
- Author
-
Jude, Chenge, Madeline E, Kavanagh, Max D, Driscoll, Kirsty J, McLean, Douglas B, Young, Teresa, Cortes, Dijana, Matak-Vinkovic, Colin W, Levy, Stephen E J, Rigby, David, Leys, Chris, Abell, and Andrew W, Munro
- Subjects
Bacterial Proteins ,Cytochrome P-450 Enzyme System ,Protein Domains ,Mycobacterium tuberculosis ,Mass Spectrometry ,Article - Abstract
Mycobacterium tuberculosis (Mtb) causes the disease tuberculosis (TB). The virulent Mtb H37Rv strain encodes 20 cytochrome P450 (CYP) enzymes, many of which are implicated in Mtb survival and pathogenicity in the human host. Bioinformatics analysis revealed that CYP144A1 is retained exclusively within the Mycobacterium genus, particularly in species causing human and animal disease. Transcriptomic annotation revealed two possible CYP144A1 start codons, leading to expression of (i) a “full-length” 434 amino acid version (CYP144A1-FLV) and (ii) a “truncated” 404 amino acid version (CYP144A1-TRV). Computational analysis predicted that the extended N-terminal region of CYP144A1-FLV is largely unstructured. CYP144A1 FLV and TRV forms were purified in heme-bound states. Mass spectrometry confirmed production of intact, His6-tagged forms of CYP144A1-FLV and -TRV, with EPR demonstrating cysteine thiolate coordination of heme iron in both cases. Hydrodynamic analysis indicated that both CYP144A1 forms are monomeric. CYP144A1-TRV was crystallized and the first structure of a CYP144 family P450 protein determined. CYP144A1-TRV has an open structure primed for substrate binding, with a large active site cavity. Our data provide the first evidence that Mtb produces two different forms of CYP144A1 from alternative transcripts, with CYP144A1-TRV generated from a leaderless transcript lacking a 5′-untranslated region and Shine-Dalgarno ribosome binding site.
- Published
- 2016
39. Head's Broadcasting in America
- Author
-
Walter Mcdowell, Paul D. Driscoll, and Michael McGregor
- Subjects
business.industry ,Download ,Political science ,Media studies ,Electronic media ,Broadcasting ,Business model ,business ,Data transmission - Abstract
This book documents the dramatic changes in the field of electronic media in the past decade and provides informed insights in the exciting, and changes yet to come. It examines the transition in broadcasting from analog to digital transmission and the changing business models of electronic media.
- Published
- 2016
40. Time course analysis of enzyme-catalyzed DNA polymerization
- Author
-
Max D. Driscoll, Julius Rentergent, and Sam Hay
- Subjects
0301 basic medicine ,DNA polymerase ,DNA-Directed DNA Polymerase ,Biochemistry ,Catalysis ,Polymerization ,03 medical and health sciences ,chemistry.chemical_compound ,A-DNA ,Klenow fragment ,DNA clamp ,030102 biochemistry & molecular biology ,biology ,Chemistry ,Oligonucleotide ,Temperature ,DNA ,Combinatorial chemistry ,Kinetics ,030104 developmental biology ,Models, Chemical ,Calibration ,biology.protein ,Thermodynamics ,DNA polymerase I - Abstract
Extracting kinetic parameters from DNA polymerase-catalyzed processive polymerization data using traditional initial-rate analysis has proven to be problematic for multiple reasons. The first substrate, DNA template, is a heterogeneous polymer and binds tightly to DNA polymerase. Further, the affinity and speed of incorporation of the second substrate, deoxynucleoside triphosphate (dNTP), vary greatly depending on the nature of the templating base and surrounding sequence. Here, we present a mathematical model consisting of the DNA template-binding step and a Michaelis–Menten-type nucleotide incorporation step acting on a DNA template with a finite length. The model was numerically integrated and globally fitted to experimental reaction time courses. The time courses were determined by monitoring the processive synthesis of oligonucleotides of lengths between 50 and 120 nucleotides by DNA polymerase I (Klenow fragment exo–) using the fluorophore PicoGreen. For processive polymerization, we were able to estimate an enzyme–template association rate k1 of 7.4 μM–1 s–1, a disassociation rate k–1 of 0.07 s–1, and a Kd of 10 nM, and the steady-state parameters for correct dNTP incorporation give kcat values of 2.5–3.3 s–1 and Km values of 0.51–0.86 μM. From the analysis of time courses measured between 5 and 25 °C, an activation energy for kcat of 82 kJ mol–1 was calculated, and it was found that up to 73% of Klenow fragment becomes inactivated or involved in unproductive binding at lower temperatures. Finally, a solvent deuterium kinetic isotope effect (KIE) of 3.0–3.2 was observed under processive synthesis conditions, which suggests that either the intrinsic KIE is unusually high, at least 30–40, or previous findings, showing that the phosphoryl transfer step occurs rapidly and is flanked by two slow conformational changes, need to be re-evaluated. We suggest that the numerical integration of rate equations provides a high level of flexibility and generally produces superior results compared to those of initial-rate analysis in the study of DNA polymerase kinetics and, by extension, other complex enzyme systems.
- Published
- 2016
41. Design and Synthesis of Metallic Nanoparticle-Ceramic Support Interfaces for Enhancing Thermal Stability
- Author
-
C. Law, S.W. Sofie, and D. Driscoll
- Subjects
Metal ,Materials science ,visual_art ,visual_art.visual_art_medium ,Nanoparticle ,Nanotechnology ,Thermal stability ,Ceramic ,Electrochemistry ,Operation temperature ,Electrochemical cell - Published
- 2015
42. Very high-energy observations of the two high-frequency peaked BL Lac objects 1ES 1218+304 and H 1426+428
- Author
-
Richard Scalzo, Douglas Gingrich, A. Jarvis, J. Ball, R. A. Ong, David A. Williams, John Kildea, D. D. Driscoll, N. Akhter, Reshmi Mukherjee, C. Mueller, D. Bramel, Jeffrey Zweerink, K. Ragan, T. Lindner, P. Fortin, D. S. Hanna, J. Carson, and Corbin Covault
- Subjects
High Energy Astrophysical Phenomena (astro-ph.HE) ,Physics ,High energy ,Astrophysics::High Energy Astrophysical Phenomena ,FOS: Physical sciences ,Flux ,Astronomy and Astrophysics ,Astrophysics ,STACEE ,High Energy Physics - Experiment ,High Energy Physics - Experiment (hep-ex) ,Solar tower ,Astrophysics - High Energy Astrophysical Phenomena ,Blazar ,Cherenkov radiation ,BL Lac object - Abstract
We present results of very-high-energy gamma-ray observations (Eγ > 160 GeV) of two high-frequency-peaked BL Lac (HBL) objects, 1ES 1218 + 304 and H 1426 + 428, with the Solar Tower Atmospheric Cherenkov Effect Experiment (STACEE). Both sources are very-high-energy gamma-ray emitters above 100 GeV, detected using ground-based Cherenkov telescopes. STACEE observations of 1ES 1218 + 304 and H 1426 + 428 did not produce detections; we present 99% CL flux upper limits for both sources, assuming spectral indices measured mostly at higher energies.
- Published
- 2011
43. Expression and characterization of Mycobacterium tuberculosis CYP144: Common themes and lessons learned in the M. tuberculosis P450 enzyme family
- Author
-
Myles R. Cheesman, Andrew W. Munro, Tanya Parish, Thomas A. Jowitt, Paul Carroll, Marjorie Howard, Max D. Driscoll, and Kirsty J. McLean
- Subjects
Time Factors ,Miconazole ,Biophysics ,Human pathogen ,Biology ,Spectrum Analysis, Raman ,Binding, Competitive ,Biochemistry ,Analytical Chemistry ,Mycobacterium tuberculosis ,Gene Knockout Techniques ,chemistry.chemical_compound ,Bacterial Proteins ,Cytochrome P-450 Enzyme System ,Escherichia coli ,Clotrimazole ,Molecular Biology ,Heme ,Gene ,Gene knockout ,chemistry.chemical_classification ,Cytochrome P450 ,biology.organism_classification ,Recombinant Proteins ,In vitro ,Kinetics ,chemistry ,Spectrophotometry ,Mutation ,Anti-Infective Agents, Local ,Potentiometry ,biology.protein ,Azole ,Electrophoresis, Polyacrylamide Gel ,Econazole ,Oxidation-Reduction ,Cell Division ,Protein Binding - Abstract
CYP144 from Mycobacterium tuberculosis was expressed and purified. CYP144 demonstrates heme thiolate coordination in its ferric form, but the cysteinate is protonated to thiol in both the carbon monoxide-bound and ligand-free ferrous forms (forming P420 in the former). Tight binding of various azole drugs was shown, with affinity for miconazole ( K d = 0.98 μM), clotrimazole (0.37 μM) and econazole (0.78 μM) being highest. These azoles are also the trio with the highest affinity for the essential CYP121 and for the cholesterol oxidase CYP125 (essential for host infection), and have high potency as anti-mycobacterial drugs. Construction of a Mtb gene knockout strain demonstrated that CYP144 is not essential for growth in vitro . However the deletion strain was more sensitive to azole inhibition in culture suggesting an important role for CYP144 in cell physiology and/or in mediating azole resistance. The biophysical and genetic features of CYP144 are compared to those of other characterized Mtb P450s, identifying both commonality in properties (including thiolate protonation in ferrous P450s) and intriguing differences in thermodynamic and spectroscopic features. Our developing knowledge of the Mtb P450s has revealed unusual biochemistry and gene essentiality, highlighting their potential as drug targets in this human pathogen.
- Published
- 2011
44. Structural and Biochemical Characterization of Mycobacterium tuberculosis CYP142
- Author
-
Andrew W. Munro, Natalia Mast, Kirsty J. McLean, Pierre Lafite, Stephen E. J. Rigby, David Leys, Max D. Driscoll, Colin Levy, and Irina A. Pikuleva
- Subjects
chemistry.chemical_classification ,Mycobacterium bovis ,biology ,Cytochrome P450 ,Fatty acid ,Cell Biology ,Metabolism ,Cholesterol 7 alpha-hydroxylase ,biology.organism_classification ,Biochemistry ,Sterol ,Microbiology ,Mycobacterium tuberculosis ,chemistry ,Gene cluster ,biology.protein ,Molecular Biology - Abstract
The Mycobacterium tuberculosis cytochrome P450 enzyme CYP142 is encoded in a large gene cluster involved in metabolism of host cholesterol. CYP142 was expressed and purified as a soluble, low spin P450 hemoprotein. CYP142 binds tightly to cholesterol and its oxidized derivative cholest-4-en-3-one, with extensive shift of the heme iron to the high spin state. High affinity for azole antibiotics was demonstrated, highlighting their therapeutic potential. CYP142 catalyzes either 27-hydroxylation of cholesterol/cholest-4-en-3-one or generates 5-cholestenoic acid/cholest-4-en-3-one-27-oic acid from these substrates by successive sterol oxidations, with the catalytic outcome dependent on the redox partner system used. The CYP142 crystal structure was solved to 1.6 Å, revealing a similar active site organization to the cholesterol-metabolizing M. tuberculosis CYP125, but having a near-identical organization of distal pocket residues to the branched fatty acid oxidizing M. tuberculosis CYP124. The cholesterol oxidizing activity of CYP142 provides an explanation for previous findings that ΔCYP125 strains of Mycobacterium bovis and M. bovis BCG cannot grow on cholesterol, because these strains have a defective CYP142 gene. CYP142 is revealed as a cholesterol 27-oxidase with likely roles in host response modulation and cholesterol metabolism.
- Published
- 2010
45. Chronic optical access through a polished and reinforced thinned skull
- Author
-
Jonathan D. Driscoll, Philbert S. Tsai, Per Magne Knutsen, Andy Y. Shih, David Kleinfeld, Pablo Blinder, Dimitrios Davalos, Katerina Akassoglou, and Patrick J. Drew
- Subjects
0303 health sciences ,Dendritic spine ,Materials science ,Extramural ,Cell Biology ,Anatomy ,Blood flow ,Optogenetics ,Mouse Skull ,Biochemistry ,03 medical and health sciences ,Skull ,0302 clinical medicine ,medicine.anatomical_structure ,medicine ,Molecular Biology ,030217 neurology & neurosurgery ,030304 developmental biology ,Biotechnology ,Drive motor - Abstract
We present a method to form an optical window in the mouse skull that spans millimeters and is stable for months without causing brain inflammation. This enabled us to repeatedly image blood flow in cortical capillaries of awake mice and determine long-range correlations in speed. We also repeatedly imaged dendritic spines, microglia and angioarchitecture, as well as used illumination to drive motor output via optogenetics and induce microstrokes via photosensitizers.
- Published
- 2010
46. Neonatal outcomes of elective early-term births after demonstrated fetal lung maturity
- Author
-
Alan T.N. Tita, Kathleen A. Jablonski, Jennifer L. Bailit, William A. Grobman, Ronald J. Wapner, Uma M. Reddy, Michael W. Varner, John M. Thorp, Kenneth J. Leveno, Steve N. Caritis, Jay D. Iams, George Saade, Yoram Sorokin, Dwight J. Rouse, Sean C. Blackwell, Jorge E. Tolosa, M. Wallace, A. Northen, J. Grant, C. Colquitt, G. Mallett, M. Ramos-Brinson, A. Roy, L. Stein, P. Campbell, C. Collins, N. Jackson, M. Dinsmoor, J. Senka, K. Paychek, A. Peaceman, M. Talucci, M. Zylfijaj, Z. Reid, R. Leed, J. Benson, S. Forester, C. Kitto, S. Davis, M. Falk, C. Perez, K. Hill, A. Sowles, J. Postma, S. Alexander, G. Andersen, V. Scott, V. Morby, K. Jolley, J. Miller, B. Berg, K. Dorman, J. Mitchell, E. Kaluta, K. Clark, K. Spicer, S. Timlin, K. Wilson, L. Moseley, M. Santillan, J. Price, K. Buentipo, V. Bludau, T. Thomas, L. Fay, C. Melton, J. Kingsbery, R. Benezue, H. Simhan, M. Bickus, D. Fischer, T. Kamon, D. DeAngelis, B. Mercer, C. Milluzzi, W. Dalton, T. Dotson, P. McDonald, C. Brezine, A. McGrail, C. Latimer, L. Guzzo, F. Johnson, L. Gerwig, S. Fyffe, D. Loux, S. Frantz, D. Cline, S. Wylie, P. Shubert, J. Moss, A. Salazar, A. Acosta, G. Hankins, N. Hauff, L. Palmer, P. Lockhart, D. Driscoll, L. Wynn, C. Sudz, D. Dengate, C. Girard, S. Field, P. Breault, F. Smith, N. Annunziata, D. Allard, J. Silva, M. Gamage, J. Hunt, J. Tillinghast, N. Corcoran, M. Jimenez, F. Ortiz, P. Givens, B. Rech, C. Moran, M. Hutchinson, Z. Spears, C. Carreno, B. Heaps, G. Zamora, J. Seguin, M. Rincon, J. Snyder, C. Farrar, E. Lairson, C. Bonino, W. Smith, K. Beach, S. Van Dyke, S. Butcher, E. Thom, Y. Zhao, P. McGee, V. Momirova, R. Palugod, B. Reamer, M. Larsen, C. Spong, S. Tolivaisa, and J.P. VanDorsten
- Subjects
Adult ,Male ,medicine.medical_specialty ,Neonatal intensive care unit ,Adolescent ,Term Birth ,Gestational Age ,Transient tachypnea of the newborn ,Article ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Intensive Care Units, Neonatal ,medicine ,Humans ,Labor, Induced ,030212 general & internal medicine ,Propensity Score ,Lung ,Hyperbilirubinemia ,030219 obstetrics & reproductive medicine ,Continuous Positive Airway Pressure ,Neonatal sepsis ,Cesarean Section ,business.industry ,Obstetrics ,Transient Tachypnea of the Newborn ,Infant, Newborn ,Obstetrics and Gynecology ,Gestational age ,Odds ratio ,Length of Stay ,Middle Aged ,Phototherapy ,medicine.disease ,Respiration, Artificial ,United States ,Logistic Models ,Elective Surgical Procedures ,Amniocentesis ,Apgar Score ,Female ,Apgar score ,Neonatal Sepsis ,business - Abstract
Background Studies of early-term birth after demonstrated fetal lung maturity show that respiratory and other outcomes are worse with early-term birth (370–386 weeks) even after demonstrated fetal lung maturity when compared with full-term birth (390–406 weeks). However, these studies included medically indicated births and are therefore potentially limited by confounding by the indication for delivery. Thus, the increase in adverse outcomes might be due to the indication for early-term birth rather than the early-term birth itself. Objective We examined the prevalence and risks of adverse neonatal outcomes associated with early-term birth after confirmed fetal lung maturity as compared with full-term birth in the absence of indications for early delivery. Study Design This is a secondary analysis of an observational study of births to 115,502 women in 25 hospitals in the United States from 2008 through 2011. Singleton nonanomalous births at 37–40 weeks with no identifiable indication for delivery were included; early-term births after positive fetal lung maturity testing were compared with full-term births. The primary outcome was a composite of death, ventilator for ≥2 days, continuous positive airway pressure, proven sepsis, pneumonia or meningitis, treated hypoglycemia, hyperbilirubinemia (phototherapy), and 5-minute Apgar Results In all, 48,137 births met inclusion criteria; the prevalence of fetal lung maturity testing in the absence of medical or obstetric indications for early delivery was 0.52% (n = 249). There were 180 (0.37%) early-term births after confirmed pulmonary maturity and 47,957 full-term births. Women in the former group were more likely to be non-Hispanic white, smoke, have received antenatal steroids, have induction, and have a cesarean. Risks of the composite (16.1% vs 5.4%; adjusted odds ratio, 3.2; 95% confidence interval, 2.1–4.8 from logistic regression) were more frequent with elective early-term birth. Propensity scores matching confirmed the increased primary composite in elective early-term births: adjusted odds ratios, 4.3 (95% confidence interval, 1.8–10.5) for 1:1 and 3.5 (95% confidence interval, 1.8–6.5) for 1:2 matching. Among components of the primary outcome, CPAP use and hyperbilirubinemia requiring phototherapy were significantly increased. Transient tachypnea of the newborn, neonatal intensive care unit admission, and prolonged neonatal intensive care unit stay (>2 days) were also increased with early-term birth. Conclusion Even with confirmed pulmonary maturity, early-term birth in the absence of medical or obstetric indications is associated with worse neonatal respiratory and hepatic outcomes compared with full-term birth, suggesting relative immaturity of these organ systems in early-term births.
- Published
- 2018
47. VERY HIGH ENERGY OBSERVATIONS OF GAMMA-RAY BURSTS WITH STACEE
- Author
-
A. Jarvis, J. Ball, R. A. Ong, Reshmi Mukherjee, C. Mueller, D. D. Driscoll, D. S. Hanna, Douglas Gingrich, John Kildea, T. Lindner, David A. Williams, K. Ragan, J. Carson, P. Fortin, T. Aune, Corbin Covault, and Jeffrey Zweerink
- Subjects
Physics ,Astrophysics::High Energy Astrophysical Phenomena ,GRB 050509B ,Astrophysics::Instrumentation and Methods for Astrophysics ,Astronomy ,Astronomy and Astrophysics ,Astrophysics ,STACEE ,Radiation ,Afterglow ,law.invention ,Telescope ,Space and Planetary Science ,law ,Gamma-ray burst ,Zenith ,Cherenkov radiation - Abstract
Gamma-ray bursts (GRBs) are the most powerful explosions known in the universe. Sensitive measurements of the high-energy spectra of GRBs can place important constraints on the burst environments and radiation processes. Until recently, there were no observations during the first few minutes of GRB afterglows in the energy range between 30 GeV and ~1 TeV. With the launch of the Swift GRB Explorer in late 2004, GRB alerts and localizations within seconds of the bursts became available. The Solar Tower Atmospheric Cherenkov Effect Experiment (STACEE) was a ground-based, gamma-ray telescope with an energy threshold of ~150 GeV for sources at zenith. At the time of Swift's launch, STACEE was in a rare position to provide >150 GeV follow-up observations of GRBs as fast as three minutes after the burst alert. In addition, STACEE performed follow-up observations of several GRBs that were localized by the HETE-2 and INTEGRAL satellites. Between 2002 June and 2007 July, STACEE made follow-up observations of 23 GRBs. Upper limits are placed on the high-energy gamma-ray fluxes from 21 of these bursts.
- Published
- 2010
48. Automatic Identification of Fluorescently Labeled Brain Cells for Rapid Functional Imaging
- Author
-
Ilya Valmianski, Yoav Freund, Jonathan D. Driscoll, David Kleinfeld, David W. Matthews, and Andy Y. Shih
- Subjects
Laser Scanning Microscopy ,Microscopy, Confocal ,Time Factors ,Physiology ,Chemistry ,General Neuroscience ,Supervised learning ,Magnification ,Posterior parietal cortex ,Somatosensory Cortex ,Somatosensory system ,Rats ,Rats, Sprague-Dawley ,Functional imaging ,Microscopy ,Innovative Methodology ,Animals ,Fluorescent Dyes ,Biomedical engineering ,Scanning microscopy - Abstract
The on-line identification of labeled cells and vessels is a rate-limiting step in scanning microscopy. We use supervised learning to formulate an algorithm that rapidly and automatically tags fluorescently labeled somata in full-field images of cortex and constructs an optimized scan path through these cells. A single classifier works across multiple subjects, regions of the cortex of similar depth, and different magnification and contrast levels without the need to retrain the algorithm. Retraining only has to be performed when the morphological properties of the cells change significantly. In conjunction with two-photon laser scanning microscopy and bulk-labeling of cells in layers 2/3 of rat parietal cortex with a calcium indicator, we can automatically identify ∼50 cells within 1 min and sample them at ∼100 Hz with a signal-to-noise ratio of ∼10.
- Published
- 2010
49. Identifying disparities in germline and somatic testing in patients with ovarian cancer in a university health system
- Author
-
D. Driscoll, P.N. Kamath, Tulay Koru-Sengul, Feng Miao, Marilyn Huang, Sophia George, Brian M. Slomovitz, Matthew Schlumbrecht, and Sean Oldak
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Somatic cell ,Internal medicine ,medicine ,Obstetrics and Gynecology ,In patient ,business ,Ovarian cancer ,medicine.disease ,Germline - Published
- 2018
50. Comparison of MRSA Select Agar, CHROMagar Methicillin-Resistant Staphylococcus aureus (MRSA) Medium, and Xpert MRSA PCR for Detection of MRSA in Nares: Diagnostic Accuracy for Surveillance Samples with Various Bacterial Densities
- Author
-
L. Dominguez, Donna M. Wolk, Ron B. Schifman, D. Driscoll, and J. L. Marx
- Subjects
Microbiology (medical) ,food.ingredient ,Micrococcaceae ,Meticillin ,biology ,medicine.drug_class ,business.industry ,Antibiotics ,biochemical phenomena, metabolism, and nutrition ,bacterial infections and mycoses ,medicine.disease_cause ,biology.organism_classification ,Staphylococcal infections ,medicine.disease ,Methicillin-resistant Staphylococcus aureus ,Microbiology ,food ,Staphylococcus aureus ,medicine ,Agar ,Subculture (biology) ,business ,medicine.drug - Abstract
Rapid laboratory methods provide optimal support for active surveillance efforts to screen for methicillin-resistant Staphylococcus aureus (MRSA). Most laboratories struggle to determine the optimal use of resources, considering options to balance cost, speed, and diagnostic accuracy. To assess the performance of common methods, the first comparison of MRSA Select agar (MS) and CHROMagar MRSA (CA), with and without broth enrichment followed by a 24-h subculture to MS, was performed. Results were compared to those of the Xpert MRSA assay. For direct culture methods, the agreement between MS and CA was 98.8%. At 18 h, direct MS identified 93% of all positive samples from direct culture and 84% of those identified by the Xpert MRSA. For Trypticase soy broth-enriched MS culture, incubated overnight and then subcultured for an additional 24 h, the agreement with Xpert MRSA was 96%. The agreement between direct MS and Xpert MRSA was 100% when semiquantitative culture revealed a bacterial density of 2+ or greater; however, discrepancies between culture and Xpert MRSA arose for MRSA bacterial densities of 1+ or less, indicating low density as a common cause of false-negative culture results. Since 1+ or less was established as the most common MRSA carrier state, broth enrichment or PCR may be critical for the identification of all MRSA carriers who may be reservoirs for transmission. In this active-surveillance convenience sample, the use of broth enrichment followed by subculture to MS offered a low-cost but sensitive method for MRSA screening, with performance similar to that of Xpert MRSA PCR.
- Published
- 2009
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.